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Abstract 
Poor medication compliance can result in reduced therapeutic benefits and a need 
for additional medical services (Putnam et al., 1984). The American Association 
of Retired Persons (1984) estimates that older adults consume an average of 3 or 
more medications daily. Poor medication compliance in elderly adults may be 
due to a decline in cognitive abilities (Park & Kidder, 1996). The present study 
was conducted to detemriine if poor medication compliance among elderly adults 
is associated with declining cognitive abilities. Older adults were contrasted with 
young adults on (a) their ability to adhere to a complex, pseudo-medication 
regimen for 4 weeks, and (b) subjective ratings of their medication compliance. 
Growth curve analyses revealed no group differences in self-reported compliance 
or change in self-reported ratings over time. Older adults demonstrated better 
medication compliance, as well as greater improvement in compliance over the 4 
weeks. The results suggest that healthy older adults can successfully adhere to a 
complex medication regimen. Thus, other factors besides cognitive ability may 
be implicated in poor medication compliance by elderly adults. 
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Medication Compliance 1 
Memory and Medication Compliance in Young and Elderly Adults 
Medication compliance can be defined as using medication correctly, as 
prescribed by a physician. This includes taking medication at the right time, in 
the correct amount, and adhering to special instructions (Park &Kidder, 1996). 
Medication nonadherence, on the other hand, includes behaviours such as 
errors of commission (missing a dose), quantity errors (taking the wrong dose), 
time errors (taking at the incorrect time), and selective nonadherence (omitting 
doses entirely). 
Medline, PsycLit, and Uncover were used to identify previous studies 
on medication compliance in the elderly. According to a substantial body of 
research, medication noncompliance is a major problem for older adults. 
Estimates of nonadherence rates among elderly adults are high. For instance, 
Kieman and Isaacs (1981) estimated the rate of nonadherence to be 40%. 
Kendrick and Bayne (1982) reported even higher rates, ranging from 47% to 
65%. Some estimates suggest that only 70 to 75% of prescribed medication is 
taken, regardless of the convenience of the dosing schedule (Cramer, Scheyer, 
& Mattson, 1990). Recently, research showed that 32 to 45% of older adults 
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do not adhere to their medication regimens (Isaac, Tamblyn, & McGill- 
Calgary Drug Research Team, 1993; Morrow, Leirer, & Sheikh, 1988). 
Similarly, Salzman (1995) has identified inappropriate drug discontinuation as 
a major problem for older adults. It is estimated that older adults will cease 
medication use prematurely in up to 40% of cases (Salzman, 1995). 
Various reasons have been suggested for poor medication compliance. 
These range from human factor variables (e g., difficulty opening the 
medication container) (Kendrick & Bayne, 1982), physician interaction style 
(Drury, Wade, & Woolf, 1976), patient embarrassment about their perceived 
level of noncompliance (Roth & Caron, 1978), and degree of social isolation 
(Schwartz, Wang, Sitz, & Goss, 1962). Furthermore, many older adults 
purposely omit medication doses (Morrel, Park, & Poon, 1989). A study by 
Cooper, Love, & Raffoul (1982 ) showed that 70% of medication nonadherence 
is intentional (Cooper, Love, & Raffoul, 1982). Common reasons for 
omissions include fear of being over medicated (Cooper et al., 1982; 
Hemminki & Hammarlund, 1975), and unpleasant side effects (Hemminki & 
Hammarlund, 1975; Ostrom, Hammarlund, Christensen, et al., 1985). 
Poor medication compliance can seriously affect the quality of patient 
health care (De Geest, von Renteln-Kruse, Steeman, Degraeve, & Abraham, 
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1998; Dimatteo & DiNicola, 1982; Haynes, Taylor, & Sackett, 1979). 
Negative effects include reduced therapeutic benefit, and an unnecessary need 
for additional medical services (e.g., diagnostic evaluations, medications) (De 
Geest et al., 1998; Putnam, Finney, Barkley, & Bonner, 1994). This is a 
particular concern for the elderly population, as they consume approximately 
half of all prescription drugs (French, 1994; Swafford, 1997). Park (1992b) 
similarly noted that 34% of older adults are taking three or more prescribed 
medications daily. 
It is important to note that the majority of cognitive aging studies used a 
cross-sectional design. As such, aging effects are identified by comparing 
subsamples that differ in age, but are assumed to be matched in all other 
aspects (Salthouse, 1982). Because of the fact that quasi-experimental designs 
prevent random assignment of study participants, the internal validity of the 
study may be threatened. In aging research, a major threat to internal validity 
is cohort effects (Schaie, 1988). Thus, age-related differences emerging from 
cross-sectional studies may be exaggerated. 
Self-Reported Medication Compliance 
Self-reported medication compliance may be described as “an estimate 
of one’s memory ability within the particular memory domain of medication 
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taking” (Gould, McDonald-Miszczak, & King, 1997, p. 319). Self-reports are 
typically used by physicians and pharmacists to monitor and modify medication 
regimens. It has been suggested that up to two-thirds of patients might have 
their regimens adjusted incorrectly (Rudd, 1993). Some patients may be using 
higher doses of medication than required (Rudd, Byyny, Zachary, LoVerde, 
Titus, Mitchell, & Marshall 1989), and consequently are at an increased risk of 
suffering drug-related side effects (Rudd et al., 1989). 
Self-reported compliance is generally regarded as a limited measure of 
adherence behaviour (McElmay, McCallion, al-Deagi, & Scott, 1997; Norell, 
1981; Park & Kidder, 1996; Rickels & Briscoe, 1970; Roth, 1984). In a recent 
study by Straka, Fish, Benson, and Suh (1997), 67% of older adults were found 
to overestimate their self-reported compliance when monitored by a 
computerized Medication-Event Monitoring System (MEMS-4). Strecher, 
Becker, Clark, and Prasada-Rao (1989) state that the extent of accurate recall is 
probably less than two weeks. Beyond this time, the authors suggest that self- 
reports offer only “a simple estimate of average compliance, but little chance 
of an accurate, reproducible summary of specific doses taken versus missed” 
(p. 164). 
Another limitation of self-reports is that patients often overestimate 
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their compliance behaviour (Norell, 1981; Rudd, 1990; Spector, Kinsman, 
Mawhinney, Siegel, Rachelsfsky, Katz, & Rohr, 1986). For instance, Haynes, 
Taylor, Sackett, Gibson, Bemholz, and Muckherjee (1980) reported that 
participants in their study overestimated their compliance by an average of 
17%. Similarly, Fletcher, Pappius, and Harper (1979) found that 83% of the 
patients in their medication study claimed perfect compliance. However, only 
2% of the participants achieved perfect compliance. 
Although often inaccurate, self-reports are one of the best measures of 
compliance. Pill counts can conceal nonadherence by throwing away pills not 
taken. In addition, pill counts do not permit the measurement of incorrect self- 
medicating (e g., taking two medications at once) or following special 
instruction (e.g., take pill with food) (Leirer et al., 1988). Clinicians’ personal 
assessments of patients compliance are often unreliable (Caron & Roth, 1977; 
Mushlin et al., 1977). Direct measures such as blood and urine tests are costly 
and inconvenient to the patient (Leirer et al., 1988). In addition, blood and 
urine analysis provide no details about the pattern of nonadherence. For 
example, regarding drugs that clear the system quickly, a blood test yields 
steady-state levels that are not representative of the patient’s typical 
compliance. Electronic pill dispensers are immobile, unnatural and disruptive 
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to the older adults’ normal lifestyle. Thus, data collected in this fashion may 
not represent the typical adherence patterns of elderly adults. 
Self-reports have the potential to be accurate. Strecher et al. (1989) 
report that many studies report high agreement between self-report and 
objective measures. Self-reports provide data that is often unattainable 
through biochemical or other independent techniques. In addition, they can 
yield a greater depth of information than is produced by other approaches. 
Cognitive Factors Involved in Medication Compliance 
Nonadherence rates among young and older adults are surprisingly 
similar (Morrel, Park, & Poon, 1989). However, cognitive factors play a more 
substantial role in medication compliance for older adults (Park, 1992b; Ruscin 
& Semla, 1996). Medication compliance can be better understood by 
examining the cognitive components of compliance. Park (1992b) has 
suggested that medication compliance consists of four major cognitive 
components. These include comprehension, working memory, long-term 
memory, and prospective memory. 
Comprehension 
Park (1992b) defines comprehension, as it relates to medication-taking. 
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as the ability to “understand the instructions presented on the individual 
prescription for taking the medication” (p. 469). Older adults are at a 
disadvantage regarding their comprehension and long-term memory abilities 
for unfamiliar medication (Park, Morrell, Frieske, & Kincaid, 1992). An 
important factor contributing to the poor medication compliance of older adults 
is their difficulty in understanding and remembering medication information 
(Morrel et al., 1990). Typically, inexplicit medication instructions are provided 
on the prescription bottle. These instructions are problematic for older adults 
due to the age-related decline in their comprehension abilities (Salthouse, 
1982). Inexplicit instructions require that the patient make inferences about 
the medication-taking procedure (e g., the exact time of day to take the 
medication), an ability that declines with age (Cohen, 1981). In a study by 
Morrell et al. (1989), the ability to comprehend medication instructions was 
compared for young and older adults. Participants were provided with 
prescription information in either a highly organized format or a typical 
medication dispensing format. Those in the highly organized format received 
prescription bottles that contained detailed information and a specific 
medication-taking schedule. Participants in the typical medication dispensing 
format were provided with prescription bottles labelled with inexplicit 
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medication information and received verbal instructions from a pharmacist on 
how to take the medication. Older adults exhibited substantial difficulty 
understanding medication information when it was presented in the typical 
medication dispensing format. However, both groups showed little difficulty 
understanding the information when it was presented in the highly organized 
format. These findings suggest that older adults can achieve similar 
compliance rates to younger adults. However, it is necessary that the 
medication instruction are detailed and do not require elderly adults to make 
inferences, or to rely on their comprehension abilities. Hultsch and Dixon 
(1983) similarly found that age differences in memory for medication 
information are less prominent when older adults are familiar with the 
medication regimen. 
Prospective Memory 
Prospective memory, remembering to do something in the future 
without being reminded, is particularly important for older adults in critical 
tasks such as taking medication and remembering appointments (Leirer, Tanke, 
& Morrow, 1994). Despite the importance of prospective memory, research 
has given little attention to it (Ceci & Bronfenbrenner, 1985; Harris, 1983). 
Recent studies have examined the effects of age on prospective 
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memory. The results are inconclusive, with some studies showing that 
prospective memory declines with age (Cockbum & Smith, 1988; Dobbs & 
Rule, 1987), while others show little effect (Sinnott, 1986; West, 1988) or a 
beneficial effect (Martin, 1986; Moscovitch, 1982). Craik (1986) proposed 
that age deficits in prospective memory can be attributed to a decline in self- 
initiated retrieval processes. Since prospective memory requires self-initiated 
retrieval, this task should be particularly difficult for the elderly as it involves 
memory for activities to be performed in the future. Einstein and McDaniel 
(1990) note that there are varying degrees in which prospective memory 
requires self-initiated retrieval, and suggest that the level of self-initiated 
retrieval is dependent on whether the task is event-based or time-based. For an 
event-based task, the future action is done when an external cue (e.g , a 
specified word) prompts remembering. A time-based task requires the 
individual to remember to respond at a specified time, without the benefit of a 
specific external cue. Thus, one would anticipate that an event-based 
prospective memory task would not produce large age-related effects, due to 
the presence of external cues that serve as a precursor to retrieval. Findings by 
Einstein & McDaniel (1990) support this theory, as they failed to find age 
differences on event-based prospective memory tasks. However, they did find 
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marked deficits on retrospective memory tasks. 
Prospective memory comprises two factors, a prospective component 
and a retrospective component (Einstein Holland, McDaniel, & Guynn, 1992). 
The prospective memory component requires that the target event 
spontaneously evoke one’s memory. The retrospective component involves 
remembering what is to be done, and appears to parallel retrospective cued- 
recall tasks when the prospective task is event-based (Einstein et al., 1992). 
Once an external cue (e.g., a specified word) triggers prospective memory, the 
retrospective portion of the task must be recalled (e.g., write one’s name). Past 
studies may have been unable to find age differences in prospective memory 
because the retrospective portion of the prospective task was too simple 
(Einstein et al., 1992). More recent analyses show that young adults were 
better than elderly adults at complex prospective memory tasks because of the 
increased difficulty of the retrospective memory component. 
Research shows that large age differences in time-based prospective 
memory tasks exist due to the significant amount of self-initiated retrieval 
(Einstein, McDaniel, Richardson, Guynn, & Gunfer, 1995). Findings from 
Einstein et al.’s (1995) research lends support to this theory. They provided 
evidence that self-initiated retrieval was necessary for successful completion of 
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a time-based prospective memory task. 
Regarding medication-taking, the prospective component appears to be 
a time-based retrieval task, as medications are to be taken on a time-based 
schedule (Park & Kidder, 1996). Due to the high self-initiated processing 
demands of time-based tasks, one would expect that medication-taking would 
be a difficult task, especially for older adults (Park & Kidder, 1996). It has 
been suggested that specific techniques (e g., linking medication taking to 
meals) could be used to transform a time-based task into a simple event-based 
task (Maylor, 1990). However, this may not be possible with complex 
medication regimens (Kruse, Eggert-Kruse, Rampmaier, Runnebaum, & 
Weber, 1991; Norell, 1980). It has been well established that as the complexity 
of medication regimens increase, compliance decreases (Kruse, et al., 1991; 
Norell, 1980; Alfredsson & Norell, 1981; Hermann, 1973). As the number of 
medications increase, an increased memory load results. When an older adult 
is taking many medications, coming up with many routine events that can be 
linked to medication-taking is difficult. In addition, it becomes increasingly 
difficult to perform their routine events at evenly spaced times throughout the 
day (in accordance with the medication regimen). 
Kruse, Eggert-Kruse, Rampmaier, Runnebaum, and Weber (1991) 
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found that as the number of doses per day increases, adherence will decrease. 
Norell (1980) found that the proportion of missed doses for a medication taken 
three times were higher than for a twice daily regimen. It also was shown that 
timing the doses for a three-times daily regimen (Alfredsson & Norell, 1981) is 
more problematic than timing doses for a twice daily regimen (Hermann, 
1973). Therefore, it is plausible that each additional medication would provide 
an increased memory load for the individual, while the high number of doses 
would make it difficult to come up with routine events that are equally spaced 
(Park & Kidder, 1996). 
Retrospective Memory 
Deficits in the domain of retrospective memory are well documented 
(Hultsch & Dixon, 1990; Smith, 1996). Simply put, retrospective memory is 
memory for past events (e.g., remembering someone’s name) (Einstein & 
McDaniel, 1990). Retrospective memory is very important to medication- 
taking as individuals must monitor the total number of medications in their 
regimen (Park & Kidder, 1990). The retrospective component of medication 
compliance becomes increasingly important considering the complexity of 
information associated with each medication (e.g., dosages, time of day, side 
effects) (Park & Kidder, 1996). For instance, Park and Kidder (1996) have 
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found it is not uncommon for elderly adults to be taking eight or more 
medications. Salthouse (1991) suggests that an important factor to consider is 
that cognitive decline is particularly pronounced from 70 years of age and 
beyond. Furthermore, the incidence of cognitive impairement in older adults 
(65 years of age and older) ranges from 3% to 20%, depending on the 
measurement and criteria used to assess cognitive functioning. Thus, older 
adults may not have the appropriate cognitive resources regarding the 
retrospective facet of medication compliance (Park & Kidder, 1996). 
Retrospective memory consists of long-term memory and working memory 
(Park & Kidder, 1996). 
Long-Term Memory. Broadly defined, long-term memory is 
information retained for extended intervals of time. This time ranges from 30 
seconds to the remainder of an individual’s life span (Femald & Femald, 
1985). Salthouse (1991) explains that long-term memory consists of an 
encoding, storage, and retrieval phase. The encoding phase refers to a range of 
processes, beginning with sensing and perceiving information, to elaborating 
and organizing incoming information with existing knowledge. Next, the 
storing of information, from the time of initial input until the information is 
later recall, is known as the storage phase. Lastly, the retrieval phase involves 
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accessing previously encoded and stored information for current processing. 
Research shows that long-term memory abilities decline with age (Light 
& Anderson, 1983; Albert, Heller, & Milberg, 1988; Salthouse & Mitchell, 
1989). The earliest work on long-term memory, as it relates to medication- 
taking, was conducted by Ley and colleagues (Ley, 1979; Ley, Whitworth, 
Skilbeck, Woodward, Pinsent, Pike, Clarkson, & Clark, 1976). In their 1976 
study. Ley et al. discovered that as age increased, individuals were more likely 
to forget medication information. 
Older adults appear to be at the greatest disadvantage in recall abilities 
when they have limited retrieval information (Craik, 1977). In medication- 
taking situations, older adults are required to use their long-term memory 
abilities to recall medication information. Typically, medication instructions 
are explained by a pharmacist when the medication is initially dispensed. After 
the initial instruction, patients are forced to rely on the limited information 
available on the prescription bottle. When difficulties are experienced in 
recalling medication instructions, elderly adults must compensate for deficits in 
long-term memory. Thus, older adults must rely on previous medication-taking 
instances to recall successfully how to take the medication correctly. In 
addition, they are forced to make inferences about the medication taking 
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procedure (Cohen, 1981). Unfortunately, both self-generated “reconstructive 
activities” and inferential abilities have been shown to decline with age (Craik, 
1977; Cohen, 1981). 
Elderly adults are also at a disadvantage when attempting to recall 
novel information. Thus, older adults may experience substantial difficulty 
remembering new and unfamiliar medication. Park, Smith, Monell, Puglisi, 
and Dudley (1990) state that older adults also have difficulties organizing and 
integrating information in long-term memory. This difficulty is exacerbated 
when the amount of presented information is increased (Cerella, Poon, & 
Williams, 1980). Many older adults follow complex medication regimens 
(Park & Kidder, 1996) and due to limitations in their recall abilities (Morrel et 
al., 1990), their compliance is often poor. 
A common technique used for measuring retrospective memory for 
medication taking is subject performed tasks (SPTs). These are activity- 
specific long-term memory tasks that involve remembering actions performed 
in everyday life (West, 1986). SPTs are discrete, one-step actions (e.g., fold 
paper, touch nose) that participants are asked to perform and later recall 
(McDonald-Miszczak, Hubley, & Hultsch, 1996). 
Cognitive aging research (e.g., Backman, 1985, Backman & Nilsson, 
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1985; Norris & West, 1993) shows that the age differences typically observed 
in free recall can be minimized by using SPTs. The multimodal nature 
(involving vision, bearing, touch, movement), and richness (involving the use 
of concrete, real-life objects) of SPTs support encoding by older adults 
(Backman, 1985). The characteristics of SPTs are inherent in medication- 
taking behaviour. For example, medication-taking involves using concrete, 
real-life objects (e.g., prescription bottles, pills) and the use of multiple senses 
to take the medication (e.g., pick up prescription bottle, put pill in mouth). 
Backman and Nilsson (1984) suggest that the multimodal nature and richness 
of SPTs may allow elderly adults to compensate for age-deficits in recall 
abilities. Interestingly, young adults do not experience additional encoding 
when using SPTs (Backman, 1985). Rather, young adults spontaneously use 
strategies that work equally well on less rich verbal stimuli such as sentences 
and words (Backman, 1985). 
Working Memory. Working memory is important to medication-taking, 
as it is necessary for the integration of medication instructions. Craik and 
Jennings (1992) refer to working memory as “the processes and structures 
involved in simultaneously holding information in mind and using that 
information (often in combination with further incoming information) to solve 
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a problem, make a decision, or learn some new concept” (p.56). Working 
memory is essential for organizing medications in a regimen, and correctly 
timing the respective doses (Park, 1992b). 
Working memory is implicated in medication compliance, because, 
when several medications comprise an individual’s regimen, an increased 
demand for short-term storage and processing of medication information 
results. Moreover, older adults are likely to be following complex, multiple 
drug regimens (Morrel et al., 1989). Additionally, research shows that older 
adults have difficulty adhering to complex medication regimens (Einstein, et 
al., 1992). As a result, older adults age-related decline in working memory 
abilities is further taxed by the increased complexity of the task. Thus, when 
older adults use organizational devices (e g., pill organizers) that support 
working memory and assist in simplifying complex medication regimens, 
adherence improves (Park et al., 1992). 
Specifically, age-related differences in working memory are related to 
age decrements in the capacity of storage, the efficiency of processing and in 
the combination of storage and processing (Babcock & Salthouse, 1990; Dobbs 
& Rule, 1989; Salthouse, 1991). However, Salthouse and colleagues 
(Salthouse & Babcock, 1991; Salthouse, 1991; Salthouse, 1992a; Salthouse & 
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Kersten, 1993) have shown that the major factor concerning age differences in 
working memory is efficiency of processing speed. In various studies using 
different samples and different measures for working memory and processing 
speed, statistical controls showed that 71% to 96% of the age-related variance 
in measures of working memory is shared with measures of processing speed. 
Thus, it appears that older adults are slower than young adults at encoding 
information or activating information. As such, older adults may take longer to 
encode medication information when learning the regimen. In addition, older 
adults will likely exhibit more difficulty activating medication instructions 
during medication-taking instances. 
Complexity of Medication Regimens 
The complexity of a medication regimen refers to “both the number of 
different pills required each day and the number of doses prescribed for each 
pill” (Boczowski & Zeichner, 1985, p. 10). Complexity is an important 
variable in explaining medication compliance (Lipton & Baird, 1993; Hulka, 
Kupper, Cassel, & Efird, 1975; Kruse et al., 1991), and may be the variable 
most consistently related to medication noncompliance (Boczowski & 
Zeichner, 1985). Medication-taking studies typically show a negative 
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relationship between patient compliance and the number of medications taken 
by the patient (Darnell, Murray, Martz, & Weinberger, 1986; Neely & Patrick, 
1968). For example, Kieman and Isaacs (1981) found that older adults taking 
one tablet daily had a 94% compliance rate. However, when the dosage was 
increased to three times daily, the compliance rate fell to 25%. A similar 
pattern was found by Kendrick and Bayne (1982). They found a 65% 
compliance rate for patients using one medication. Study participants taking 
four medications complied 54% of the time, while individuals using six 
medications dropped to a 47% compliance rate These findings suggest that 
more complex medication regimens are associated with poorer compliance. 
The ability to follow complex medication regimens is of particular 
concern for the elderly, as estimates suggest that 25% of older adults consume 
three or more medications daily (American Association of Retired Persons, 
1984). Another factor complicating the problem is that older adults experience 
a decline in cognitive abilities as they age (Park & Kidder, 1996). This 
cognitive decline increases risk for noncompliance when medication regimens 
are complex (Park & Kidder, 1996). Furthermore, following complex 
medication regimens may cause older adults to experience an “information 
overload” effect when they are presented with large amounts of written and 
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verbal prescription information (Ascione & Shimp, 1984). Morell et al. (1989) 
found that when few medications comprise the medication regimen (i.e., a low 
task demand), older adults are more likely to adhere to the medication regimen. 
However, older adults are typically in polypharmacy (multiple drug) situations, 
which places them at increased risk for noncompliance (Morrell et al., 1989). 
The Present Study 
The purpose of the present study was to examine the self-reported 
medication compliance and actual compliance behaviour in young and older 
adults. The main questions addressed by the present study included; (a) Do 
young and older adults differ in their cognitive abilities? (b) Will young adults 
exhibit more change than older adults in self-reported and actual compliance 
over a four-week period? (c) Is performance on memory tests associated with 
medication compliance over a 4 week period? (d) Will young adults show 
better recall of the medication regimen when compared with older adults? 
Cognitive factors, particularly working memory, long-term memory, 
and prospective memory, are believed to play a substantial role in medication 
compliance (Park, 1992). Processing speed may also be an important factor in 
determining medication compliance (Salthouse, 1991). Research consistently 
shows that older adults show age-related decline in memory ability (ref). As 
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such, the initial hypothesis is as follows: 
1. The young group will show better event-based prospective memory, 
time-based prospective memory, working memory, and faster speed of 
processing when compared with older adults. 
It is well-documented that older adults show age-related differences in 
retrospective memory ability (Hultsch & Dixon, 1990, Smith, 1996). However, 
Backman and Nillson (1985) suggest that using an activity-specific 
retrospective memory task will reduce age differences in retrospective memory 
ability. As such, it is hypothesized that: 
2. No differences will emerge between young and older adults on 
retrospective memory abilities when an activity-specific task is used (e g., 
subject-performed task). 
Another important factor interfering with proper medication 
compliance is the complexity (i.e., daily medications and doses) of the 
medication regimen (Lipton & Baird, 1993; Kruse et al., 1991). Since older 
adults are typically following complex medication regimens, they are at an 
increased risk for noncompliance (Morrell et al., 1989). Thus, the following is 
hypothesized: 
3. The elderly group will perceive the medication regimen to be more 
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complex than the young group. 
Research shows that young and older adults are often inaccurate in their 
self-reported medication compliance (Strecher et al, 1989). However, because 
young adults are at the peak of their cognitive abilities (Salthouse, 1991), they 
may demonstrate more accurate self-reporting. This may be due, in part, to 
their superior ability to recall past medication-taking episodes. Moreover, as 
the young adults become more accustomed to recalling specific past 
medication-taking episodes, they will likely show greater improvement in self- 
reported compliance over time. As such, it is expected that; 
4. The young group will show greater improvement in self-reported 
compliance when compared with the elderly group during the four-week 
regimen. 
5. The young group will rate their compliance higher than the elderly 
group. 
It is well-established that comprehension, prospective memory, 
retrospective memory, and working memory are crucial factors in successful 
medication compliance (Park & Kidder, 1996). Again, young adults 
consistently show better functioning in all these areas (Salthouse, 1991). 
Moreover, as young adults continue to follow the regimen, the medication- 
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taking routine will become better encoded in their memory. As such, they will 
show greater improvement in medication compliance over time. 
6. The young group will show greater improvement in actual 
compliance when compared with the elderly group during the four-week 
7. The young group will show better actual compliance when compared 
with the elderly group. 
Research shows that patients often overestimate their self-reported 
compliance behaviour (Rudd, 1990; Spector et al., 1986). Thus, it is 
anticipated that: 
10. Self-reported compliance ratings for young and older adults will be 
higher than their actual compliance scores. 
Research consistently shows that long-term memory abilities decline 
with age (Salthouse & Mitchell, 1989). Thus, it is hypothesized that: 
11. The young group will rate their recall of the medication regimen 
higher than the elderly group. 
12. The young group will recall more medication information when 
compared with the elderly group. 
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Method 
Participants 
Sixty-four participants were involved in the study. The participants 
included 32 young adults (M = 22.53, = 4.55) and 32 elderly adults (M 
70.50, SD = 8.09) who were not taking prescribed medications at the onset of 
the study. The data of two young adults was excluded due to missed sessions. 
Two elderly adults voluntarily withdrew from the study. Young adults were 
recruited from introductory psychology classes at Lakehead University in 
Thunder Bay. Student participants received three percentage points toward 
their final grade in introductory psychology. Elderly participants were 
recruited from various settings, including seniors’ clubs in the Thunder Bay 
region, the volunteer pool from the Seniors’ Abilities and Life Tasks (SALT) 
project, and the Lakehead University registration list for students aged 60 and 
over. Elderly students enrolled in Introductory Psychology also received three 
percentage points toward their final grade, while the other elderly participants 
received $20 for their participation. All elderly participants lived 
independently (i.e., either alone or with their spouse). 
Procedure 
Participants attended five sessions over a four-week period. The 
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experimenter met with each participant individually. The first visit was held at 
Lakehead University and lasted approximately one hour. Participants 
completed an Informed Consent sheet (Appendix 14), the Personal Information 
Questionnaire (Appendix 1), the Centre for Epidemiologic Studies-Depression 
Scale (Appendix 2), the Metamemory in Adulthood Questionnaire (Appendix 
3)  and the Knowledge of Medication Questionnaire (Appendix 8). Next, 
participants completed several cognitive tasks including the Digital Symbol 
Subtest of the Wechsler Adult Intelligence Scale-Revised Edition (Appendix 
4) , the Sentence Construction task (Appendix 6), Subject Performed Tasks 
(Appendix 7), and the Event-Based Prospective Memory task (Appendix 5). 
The experimenter explained that participation in this study would involve 
following a four-week pseudomedication regimen, designed to mimic that of an 
older adult. Participants were asked to pretend that they were afflicted with 
four illnesses that commonly affect older adults (Hypertension, mild 
Osteoporosis, Pulmonary Disorder, and Insomnia), to use five 
pseudomedications (Adalat, Diltiazem, Calcium, Vitamin D, Restoril) and two 
inhalers (Ventolin, Atrovent) to help control their medical problems. 
Participants were asked to maintain a patient/pharmacist style relationship with 
the experimenter to provide a more realistic nature to the study and thus a more 
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accurate measure of compliance. The experimenter explained the purpose of 
taking each drug, and gave participants an information sheet with more 
detailed descriptions of each medication. The information sheet also provided 
the amount to be taken, the number of times per day, which medications were 
to be taken together, special instructions associated with the medication, and 
the side effects. 
For the purposes of this study, no medication was ingested nor were any 
inhalers used. Taking medication involved participants removing a bead from a 
labelled pill bottle and placing it into a small container provided by the 
experimenter. The container was dark-coloured with a sealed lid to prevent 
participants from seeing how many beads and stickers they had taken. Puffer 
use was recorded by giving participants a sheet of stickers. Participants 
showed mock usage of the inhaler by removing a sticker from the left pocket in 
the “puffer booklet” and placing it in the same container as the beads. 
After explaining the medication regimen, the experimenter discussed 
the importance of recording results honestly and accurately. Two weeks of 
medication was provided. The first week of medication was to be used 
immediately, while the second week of medication was enclosed in an 
envelope to be opened at the beginning of Week 2. In addition, participants 
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were given side effect information for each medication, and a calendar listing 
all future appointments. 
The second session consisted of a 30 minute telephone call. 
Participants were asked to complete two questionnaires. The Refill 
Questionnaire (Appendix 9) assessed medication-taking behaviour and other 
related factors. For instance, participants were asked to rate their medication 
compliance, indicate how complex they perceived the regimen to be, and to 
report specific strategies they used. Next, participants were asked to open the 
envelope labelled “Confidential Questionnaire” and to complete the enclosed 
questionnaire (Appendix, 10). This measure assessed voluntary noncompliance 
and the perceived importance of the study. Upon completion, participants were 
told to seal it in the envelope provided. Participants were informed that the 
envelope would not be opened until the end of the study. Participants were 
requested to open the envelope labelled “Week 2 medications” and to use the 
enclosed pill bottles for the second week of the medication regimen. In 
addition, participants were told that the experimenter would be out of town one 
day before the week three meeting. As such, the experimenter requested that 
participants phone to confirm the meeting. Participants were instructed to 
leave a message on the lab answering machine between 8:00 a m. and 12:00 
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p.m.. This served as the Time-Based Prospective Memory task (Appendix 11). 
The third visit took place at the participants home. This meeting was 
also 30 minutes. Participants completed a second Refill Questionnaire and 
Confidential Questionnaire that they again sealed in an envelope. The 
experimenter provided new pill bottles and refills of medication for the third 
and fourth weeks. Participants could begin the third week of the regimen at the 
end of the meeting, while material for the fourth week was given in an 
envelope, to be used one week later. A Confidential Questionnaire for Week 4 
was provided in a separate envelope. The experimenter collected unused 
medications from Week 1 and Week 2, and the Confidential Questionnaires. 
The fourth session was identical to the Week 2 telephone interview. 
Participants were again asked to complete the Refill Questionnaire and the 
Confidential Questionnaire. Next, they were asked to begin their fourth week 
of medication. Before finishing the session, participants were reminded to 
bring all unused medications and completed questionnaires to the final 
interview at Lakehead University. 
The final visit took place at Lakehead University and was 
approximately 30 minutes. Participants received the Refill Questionnaire and 
the Confidential Questionnaire. They also completed a Rating Questionnaire 
Medication Compliance 29 
(Appendix 12) which assessed knowledge of the medication regimen (e.g., the 
number of times per day medication was required, the appropriate dose, etc.). 
A Recall Questionnaire (Appendix 13) (consisting of the same questions as the 
Rating Questionnaire) was given, and participants were asked to provide the 
written answers to these questions. Participants were debriefed and thanked for 
their participation. 
Materials 
Personal Information Questionnaire iAppendix \ A 32-item Personal 
Information Questionnaire was developed for this study. The questionnaire 
assessed sociodemographic information, general health (e.g., hearing, eyesight, 
frequency of visits to doctor), medical conditions (e.g., heart condition, 
asthma), lifestyle questions (e g., engagement in social activities, alcohol use) 
and use of prescribed medication (present and past). 
The Digit Symbol Subtest of the Wechsler Adult Intelligence Scale- 
Revised Edition (Appendix 3Y The Digit Symbol Subtest of the Wechsler 
Adult Intelligence Scale-Revised Edition (WAIS-R; Wechsler, 1987) is a speed 
of processing task. It contains nine symbols paired with nine digits. 
Participants are provided with the matched samples and required to fill in as 
many symbols as possible under the corresponding number within 90 seconds. 
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Participants receive one point for each correct item. The maximum score is 93 
points, with higher scores reflecting greater speed of processing ability. 
Reliability ratings using the test-retest method ranged from .73 to .86 
(Wechsler, 1987). A factor analysis rating of .85 was found between the WAIS 
Full-Scale IQ and the Stanford-Binet. 
The Metamemorv in Adulthood Questionnaire (MIA. Appendix 4). The 
Metamemory in Adulthood Questionnaire (MIA; Dixon & Hultsch, 1983a, 
1983b) consists of 108 items designed to measure participants’ awareness of 
their memory functioning. The items are scored on a 5-point Likert scale 
ranging from “agree strongly” to “disagree strongly” and “always” to “never”. 
Higher scores on these scales represent heightened awareness of individual 
memory functioning. Items 15 and 38 are reverse scored. Three of the seven 
scales, namely the Capacity, Anxiety, and Strategy scales were selected for use 
in this study. The Capacity scale measures memory self-efficacy (e g., I have 
no trouble keeping track of my appointments). The Anxiety scale is a 
measurement of anxiety concerning memory-related activities (e.g., I have 
difficulty remembering things when I am anxious). The strategy scale assessed 
the use of memory strategies in everyday life. Two strategy subscales, internal 
and external strategies, were derived from the MIA Strategy scale (Dixon & 
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Hultsch, 1983b). External strategies involve physical changes in the 
environment (e.g., keeping a list or making note of important dates), while 
internal strategies require personal mental activity (e.g., using mnemonics to 
help recall something). Internal consistency analysis ranges from .81 to .86 
(Hultsch et al ., 1987; Dixon & Hultsch, 1983b) for the Capacity subscale, .83 
to 87 (Dixon & Hultsch, 1983b; Hultsch et al., 1987) for the Anxiety subscale, 
and .82 to .86 (Hultsch et al., 1987; Dixon & Hultsch, 1983b) for the Strategv 
subscale. Some evidence of predictive validity has been demonstrated (Dixon 
& Hultsch, 1983a; Dixon et al., 1986). 
Event-Based Prospective Memory Task (Appendix 5). A single event- 
based prospective memory task, presented as a cover-story, was designed for 
this study. Participants were told that printing errors may have occurred in 
their questionnaire booklets, resulting in blurry, unreadable pages. They were 
instructed to remove the blurred pages from the booklet if they encountered 
any. On these pages, they were told to record both their name and the name of 
the questionnaire in the top right-hand comer. A blurred page was 
intentionally placed in each “Memory Questionnaire”. A score of zero was 
given if the participant did not remove the blurred page from their 
questionnaire booklet. In cases where the blurred page was removed, but the 
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participant forgot to write their name and the name of the questionnaire in the 
top right-hand comer, a score of 0.5 was assigned. A full score of one point 
was given if the participant tore out the blurred page, and wrote their name and 
the name of the questionnaire in the top right-hand comer. 
Sentence Constmction Task (Appendix 6f The Sentence Construction 
task (Hultsch, Hertzog, & Dixon, 1990) is a verbal measure of working 
memory. Participants are shown a series of sentences and asked to read these 
sentences aloud, and at their normal reading pace. Each sentence is on a single 
piece of paper. In each sentence, one word is underlined and printed in capital 
letters. The participant is instructed to remember this word while reading the 
sentence. When the participant has finished reading the sentence, the 
experimenter turns the page, and the participant reads the next sentence. The 
participant is required to remember the first target word, while encountering 
additional target words in upcoming sentences. At the end of the section, 
participants are asked to report, in order, the target words from each sentence. 
The target words are ordered so that they create a sentence. In total, four sets 
of sentences produce new sentences that are 3, 4, 5, and six words in length. 
Three sentences of each length are included, totalling 12 items. Two initial 
sample items are included to ensure that the participant understands the task. 
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One point is given for the exact recall of the sentence. If the participant fails to 
recall less than two sentences correctly in a given section, no points are 
awarded. The maximum score that can be obtained is 12. 
Subject Performed Tasks (SPT. Appendix 7\ Subject Performed Tasks 
(SPT’s) is an activity-specific retrospective memory task, introduced by Cohen 
(1981). SPTs involve memory for actions performed in everyday life. The 
experimenter verbally presents 35 action pairs to the participant, one item at a 
time. An action pair consists of two words presented together, which describe 
a common activity (e g., cross legs, shuffle cards, raise eyebrows). After the 
presentation of each action pair, the participant is required to repeat the item 
aloud, and then perform the action. Participants receive a 10-second time- 
delay between each item, to allow for further encoding of the action pair. At 
the conclusion of the list, participants are informed that they will receive seven 
minutes to record as many action pairs as possible. Before presenting the list 
of SPT’s, participants are asked to make a prediction regarding the number of 
action pairs they expect to recall. This is known as a global prediction task. 
Participants are required to select a number between one and 35, with 35 
representing a perfect score. This task was scored using three different 
methods. One scoring method involved assigning a single point for each 
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correct pair, with a maximum score of 35. A second method involved allotting 
a point for each word recalled correctly, with a maximum score of 70. For the 
third scoring method, a single point was given for each correct word, while also 
allowing for the inclusion of synonyms. The maximum score that could be 
achieved with this method is 70. 
Knowledge of Medication Questionnaire (Appendix 8V The 
Knowledge of Medication Questionnaire was developed for this study. This 
61-item measure was designed to assess the participant’s prior knowledge of 
the medications used in this study. Sample items include “Have you heard of a 
medication called Adalat?”, and “Do you know how many times daily this 
medication is to be taken?”. This questionnaire served as a screening 
instrument as prior knowledge of the medications used in this study could 
potentially influence participants’ compliance and recall. 
Refill Questionnaire (Appendix 9). A Refill Questionnaire was 
developed to monitor the medication-taking behaviour and other 
miscellaneous factors that could potentially influence compliance (e g., self- 
rated compliance behaviour, perceived complexity). Sample items included 
“How would you rate your compliance with your medication regimen over the 
last week?”, and “How complex did you find the medication regimen?”. The 
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Refill Questionnaire was administered at the end of each week. 
Confidential Questionnaire (Appendix lOY A 4-item Confidential 
Questionnaire was developed as an extension of the Refill Questionnaire, to be 
completed at the end of each week. Participants were informed of the 
confidential nature of this questionnaire, and asked to seal it in an envelope 
that would be opened by the experimenter at the conclusion of the study. This 
questionnaire assessed voluntary noncompliance (e.g., How many days or parts 
of days, did you choose not to take your medication ...?), and perceived 
importance (e g., . . . how important is it for you to remember to take your 
medication correctly for the purposes of this study?). 
Time-Based Prospective Memory Task (Appendix 11). A time-based 
prospective memory task (presented as a cover story) was assigned for this 
study. During the second session (a telephone interview), participants were 
reminded that the experimenter would phone one day before the scheduled 
meeting to confirm the upcoming session. However, regarding the next 
meeting (session three), the experimenter was to be out of town one day before 
the session and would be unable to phone and confirm the meeting. Therefore, 
the participant was asked to phone the lab at a predetermined time (i.e., 
between 8:00 a.m. and 12:00 p.m ). Participants were also instructed to leave a 
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message stating whether they could attend the upcoming meeting. The 
experimenter emphasized that phoning during the predetermined time was 
necessary, as the answering machine would only be on at this time (after which 
it would be turned off due to testing in the lab). Participants that did not phone 
the lab, or who phoned outside the predetermined time were assigned a score of 
zero. Those who telephoned during the predetermined time received a score of 
one. 
Rating Questionnaire (Appendix \2). The 6-item Rating Questionnaire 
was developed for this study. Participants were asked to rate their recall 
regarding several key facets of medication-taking. Sample items include “Do 
you remember what each specific medication is designed to treat?”, and “Do 
you remember the side effects associated with each medication?”. Participants 
indicated their responses to each question with a percentage rating (ranging 
from 0 - 100). 
Recall Questionnaire ( Appendix 131. A 6-item Recall Questionnaire 
was developed for this study. This 6-item scale was identical to the Rating 
Questionnaire with the exception that responses are required in written form. 
The Centre for Epidemiologic Studies - Depression Scale (CES-D. 
Appendix 2). The Centre for Epidemiologic Studies - Depression scale (CES- 
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D; Radloff, 1977) is a 20-item questionnaire used to identify depressive 
symptomatology. The items are scored on a 4-point Likert scale ranging from 
“rarely or none of the time” to “most or all of the time.” Higher scores on 
these scales reflect more depressive symptomatology. Items 4, 8, 12, and 16 
are reversed scored. Sample items include “During the past week my sleep was 
restless,” and “During the past week I felt sad.” In the present study, the CES- 
D was used as a screening instrument to identify participants with high scores 
in depressive affect, as depression may contribute to inaccurate prediction or 




The groups were compared on several potential extraneous variables, 
such as mood, demographics and beliefs about one’s memory (see Table 1). 
The presence and severity of a depressed mood at the initial interview were 
compared between young and older adults to rule out the influence of current 
levels of depression. Both the young and elderly adults showed negligible 
depressive symptomatology. Next, the two groups were compared on beliefs 
about their memory. Young and older adults showed similar levels of anxiety 
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regarding their memory, self-efficacy, and internal strategy use. However, the 
young group reported higher incidences of external strategy use when 
compared with older adults, t (2, 58) = 2.98, p = .004, r = .36. 
The groups were similar on most personal variables including number 
of daily social activities, number of visits to the doctor in the past 12 months, 
number of prescribed medications used in the last two years, and the use of 
hearing and vision aids. Young and elderly adults generally rated their overall 
state of health as good or very good. However, the two groups differentiated 
when a comparison was made regarding personal perceptions of their overall 
state of health with other people their age. Older adults rated their overall state 
of health higher than younger adults, t (2, 58) = 3.89, p = .000, r = .46. Prior 
knowledge of the medications used in the study was also assessed. No group 
differences were found involving prior medication knowledge. Both groups 
reported having very limited knowledge of the medications used in the study. 
Group Differences in Memory Abilities 
Young and older adults were compared on several types of memory, 
including (1) event-based prospective memory, (2) time-based prospective 
memory, (3) retrospective memory, (4) working memory, and (5) speed of 
processing. First, regarding event-based prospective memory, the young group 
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showed better recall on the event-based prospective memory task than the 
elderly group, t (2, 58) = 2.52, p = .015, r = .31. Second, young and older 
adults were tested on a time-based prospective memory task. Contrary to the 
hypothesis, no significant differences emerged between the two groups. Third, 
both groups were compared regarding retrospective memory ability. As 
anticipated, the young adults exhibited better retrospective memory 
performance when compared with the older adults, t (2, 58) = 3.71, g = .000, r 
= .44. Fourth, differences in working memory ability were examined. 
Contrary to the hypothesis, no group differences were demonstrated between 
the two groups. Fifth, young and older adults were compared on their speed of 
processing ability. It was expected that the young adults would exhibit superior 
speed of processing ability. As hypothesized, the young group demonstrated 
faster speed of processing than the older adults, t (2, 58) = 5.70, p = .000, r = 
.60. 
Group Differences in Perceived Complexity and Perceived Importance 
Young and older adults were asked to rate their perceptions of the 
complexity of the medication regimen. Although it was hypothesized that the 
young adults would rate the regimen as less complex, no significant group 
differences emerged. However, the finding did approach significance, t (2, 58) 
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= 1.95, p = .056, but not in the expected direction. Contrary to the hypothesis, 
the young adults rated the medication regimen as more complex than the older 
adults. 
Participants were also asked to rate how important they believed it was 
to follow the medication regimen in the study. The young adults perceived the 
task to be less important than the older adults, t (2, 58) = -4.22, p = .000, r = 
.49. 
Growth Curve Analyses 
Common techniques used for analysing longitudinal data (e g., zero- 
order correlations, t-tests, analysis of variance) can provide an incomplete 
picture of the data. The above statistical techniques are also limited to 
analysing two waves of data. This can present an incomplete picture of the 
data. In samples where large differences in development exist between 
individuals, examining only two mean values may distort the picture of change 
that emerges over time. As such, the focus on associations between initial 
measurements and final outcomes is inaccurate and likely unreliable, as change 
over time is not accounted for. Following individual time paths is the best 
measurement of individual change (Kamey & Bradbury, 1996). 
Growth curve analysis is a method of approaching multi wave data that 
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offers flexibility, while providing a clear focus on continuous processes of 
individual development. Growth curve analyses consist of two stages. In the 
first stage, the repeated-measures data for each individual are used to estimate 
the trajectory (i.e., slope and intercept) of each individual’s dependent variable 
scores over time. The trajectory is calculated by regressing the dependent 
variable onto times of measurement. As a result, the slope (an estimate of the 
rate of linear change in the dependent variable score over time) and intercept 
(the expected value of the dependent variable score when time equals zero) 
provide an estimate of the trajectory of change over time. Thus, multiple 
waves of data are reduced to two parameters, slope and intercept, and an error 
term to summarize the observed trajectory for each person. 
In the second stage of growth curve analysis, the parameters of the 
individual trajectories (i.e., growth curves) are treated as outcome variables to 
be explained by other contextual variables in a between-subjects analysis. For 
example, in the present study, the slope and intercept values for the dependent 
variables (self-reported compliance and actual compliance) become the 
dependent variables. Statistical analyses are then performed using the 
independent variable (group), and the new dependent variables (slope and 
intercept values). 
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Regarding the present study, the longitudinal changes in the dependent 
variables, self-reported compliance and actual compliance, can be assessed by 
examining the trajectory over time of each participant’s dependent variable 
scores. To achieve this, growth curve analysis was used to examine and 
describe the longitudinal trajectories. 
The first step in growth curve analysis is to learn where the trajectories 
of the dependent variable begin. The starting point for the slope trajectory is 
the intercept, which is the expected value of a participant’s dependent variable 
score before the beginning of the study. Since a prior measurement of 
medication compliance does not exist for these participants, creating an 
intercept value was necessary. This was accomplished by centering the 
intercept value in the middle of the four measurement periods and labelling it 
as time zero. The intercept can now be interpreted as the average value of an 
individual’s dependent variable across the duration of the study (Kamey & 
Bradbury, 1996). 
Age Group Differences in Levels of Compliance 
Self-reported compliance intercept values (see Table 2) for the young 
and elderly groups were then compared. Growth curve analysis revealed no 
significant difference in estimated intercept scores, t (2, 58) = -1.69, p = .097, 
Medication Compliance 
n.s., r = .22. 
Actual compliance intercept values (see Table 2) were also compared 
for the two age groups. A significant difference in actual compliance intercept 
values emerged between young and older adults, t (2, 58) = 2.33, p = .02. 
Unexpectedly, the elderly participants had a higher actual compliance intercept 
value when compared with the younger participants, r = .29. This finding 
demonstrates a significant difference in intercept values between the young and 
elderly group. 
Change in Compliance Over Time 
The next step in the analyses involved examining how self-reported 
compliance and actual compliance scores changed over time. As for self- 
reported compliance, the slope trajectories (see Table 3) for young adults 
decreased an average of 1.26 points in self-ratings each week from the initial 
starting point (see Figure 1). Conversely, the elderly participants increased an 
average of 0.34 points each week from the initial intercept value (see Figure 2). 
The average slope of the population, however, can be misleading concerning 
the variability among individual scores. The low average slope value shows 
that little variability exists among the individual estimated slopes. In actuality, 
the individual estimated slopes range from -27.90 to +19.00 for the younger 
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adults, and from -6.50 to 13.50 for the elderly adults. Clearly, wide variability 
is present among individual scores. Some younger adults declined nearly 28 
points in self-reported compliance ratings between each phase of measurement, 
while others increased as much as 19 points. Similarly, some older adults 
declined as much as 6.5 points, while others improved up to 13.5 points. 
Due to the wide range of scores in self-reported compliance slope 
estimates, the significance of the average slope is questionable. To test the 
significance of the average slope, the standard error was used to construct a 
95% confidence interval. Confidence intervals ranged from +1.68 to -4.20 for 
the young participants, and from +1.91 to -1.23 for the elderly participants. 
Results showed that the estimated average slope did not differ significantly 
from zero for either the young or elderly groups. This finding demonstrates 
that, overall, neither group exhibited a significant change in self-reported 
compliance ratings across the four weeks. 
Regarding the change in actual compliance scores over time, the slope 
trajectories (see Table 3) for the young group showed an average decrease of 
2.64 points each week from the initial starting point (see Figure 3). On the 
other hand, elderly participants increased 0.22 points each week (see Figure 4). 
Taken together, these results show that the performance of younger adults 
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declined, while the elderly participants improved marginally over the four 
weeks. More specifically, the young group committed an average of 2.64 
additional medication mistakes (i.e., missing a prescribed medication dose or 
taking an extra dose) each week. As for the elderly group, they committed 0.22 
fewer medication mistakes with each passing week. Again, the average slope 
may not represent the individual slope value. As such, looking at the range in 
individual estimated slopes is necessary . Upon examination, the range in 
individual slope scores was -8.60 to +25.80 for the young adults, and -7.80 to 
+7.80 for the elderly adults. Due to the wide range in actual compliance slope 
estimates, the average slope was tested to find out if it differs significantly 
from zero. If the slope differs significantly from zero, this would show that 
meaningful change has occurred in actual compliance values. Upon analysis, 
the estimated average slope of 2.64 for the young group was significant (i.e., 
found to differ significantly from zero). This result was unexpected as it was 
presumed that young participants would improve, not decline, in performance 
over the four-week medication regimen. The average slope for the actual 
compliance scores of the elderly group did not differ significantly from zero. 
No significant change in cognitive errors occurred over the four-week period. 
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Testing the Linear Model of Change 
The next question addressed by growth curve analyses concerned the 
accuracy of the linear model in accounting for variance in the repeated 
observations. Before the growth curve analyses were conducted, a straight line 
model of change was selected as the most accurate descriptor of change. 
However, based on the obtained values, it is questionable whether or not the 
linear model is the best descriptor of the individual trajectories. Concerning 
the mean coefficient of determination (R~), the straight-line model of change 
accounted for 39% of the variance in self-reported compliance (see Figures 1 
and 2). In addition, the linear model explained 35% of the variance in actual 
compliance (see Figures 3 and 4). However, caution must be taken when 
interpreting these R^ values as they can be misleading. 
For instance, individual R’ values may be low or high, because the 
dependent variable (self-reported compliance or actual compliance) is not 
changing linearly. Thus, the trajectory of self-reported compliance and actual 
compliance scores may be better described by a more complex model (i.e., a 
model that accounts for more explained variance). Another potential 
explanation is that the dependent variables are not exhibiting enough variability 
to show change over time. As such, R^ is a good descriptor of the adequacy of 
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a model across a population, but may be misleading as an estimate of linearity 
within-individuals. To correct this problem, the square root of the residual 
variance (RMSE) is used to estimate the spread of each participants’ data 
around a straight-line model of change. By calculating the RMSE, the 
variance that is unaccounted for by the linear model can be observed. For self- 
reported compliance, RMSE estimates range from zero to 20.68 among young 
and elderly participants, with an average RMSE of 6.24. As for actual 
compliance, RMSE estimates range from zero to 31.38, with an average RMSE 
of 7.59. As can be seen, the square root of the error variance ranges more than 
20 points between individual self-reported compliance ratings and more than 
30 points for actual compliance scores. Evidently, self-reported compliance 
and actual compliance do not conform ideally with the linear model of change. 
However, the straight-line model of change provides an adequate description 
of the data for many participants, because of the wide variability of scores 
around a straight line. 
Improvement in Self-Reported Compliance and Actual Compliance Scores 
Over Time 
It was predicted that the young group would show greater improvement 
in self-reported compliance ratings (see Table 2) when compared with the 
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elderly group during the four-week medication regimen. However, results did 
not show significant differences in self-reported compliance ratings over the 
four weeks between the young and elderly participants, t (2, 58) = -.94, p = 
.351, n.s., r = . 12. Next, it was hypothesized that the young participants would 
show greater improvement in actual compliance (see Table 2) when compared 
with the elderly participants over the four-week period. Significant differences 
in actual compliance performance were found, t (2, 58) = 2.04, p = .045. This 
finding was contrary to the hypothesis, as the older adults showed more 
improvement than the younger adults over time, r = .26. 
Accuracy of Self-Reported Compliance Ratings 
It was hypothesized that young and older adults would overestimate 
their self-reported compliance. Self-reported compliance and actual 
compliance scores were converted to a score out of 100. Using the converted 
scores, separate paired-sample t-tests were conducted for the young and elderly 
groups. It was found that young adults gave an average rating of 83% to their 
compliance. Their actual compliance scores were higher, at an 88% 
compliance rate. A significant difference between self-reported compliance 
ratings and actual compliance scores emerged for the young adults, t (1, 29) = 
3.54, p = .001, r = .42. This finding was contrary to the hypothesis, as it was 
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expected that the young group would overestimate (as opposed to 
underestimate) their self-reported compliance ratings. Older adults stated that 
they complied with the medication regimen an average of 88% of the time. 
However, regarding actual compliance, older adults successfully complied with 
the medication regimen approximately 92% of the time over the four weeks. In 
addition, a significant difference between self-reported compliance ratings and 
actual compliance scores were also found for the elderly adults, t (1, 29) = 
2.41, p = .023, r = .30. Again, the finding was contrary to the hypothesis, as the 
elderly group was expected to overestimate their self-reported compliance 
ratings. 
Group Differences in Self-Reported Compliance Ratings and Actual 
Compliance 
It was anticipated that the young adults would rate their compliance 
higher than the older adults. However, no significant difference was found 
between the two groups, t (2, 58) = -1.69, p = .097, n.s., r = .22. It can be 
concluded that the younger participants did not exhibit higher self-reported 
compliance ratings in comparison to the elderly adults. For the next 
hypothesis, it was expected that the young group would achieve better actual 
compliance scores when compared with the elderly group. Although a 
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significant difference in actual compliance was found, t (2, 58) = 2.33, p = 
.023, the finding opposed the hypothesis. The older adults committed 
significantly fewer cognitive errors while following the medication regimen in 
comparison to the younger, r = .29. 
Predictors of Change in Self-Reported Compliance and Actual Compliance 
Multiple regression analyses were performed to identify predictors of 
change in self-reported compliance and actual compliance for the young and 
elderly groups. No significant variables were found to predict the intercept 
values for self-reported compliance and actual compliance (see Table 4). 
However, several variables emerged as significant predictors of change for self- 
reported ratings and actual compliance (see Table 5). Event-based prospective 
memory predicted change in self-reported compliance for the young group, t (1, 
29) = -2.12, p= .04, r = .27, = 22.78, part cor = -.381, over the four-week 
period. However, no significant predictors emerged for the elderly group over 
the four-week period. Event-based prospective memory approached 
significance for the elderly group, t (1,29) = -1.87, p = .074, r = .24, = 
16.52, part cor = -.348. Regarding actual compliance, SPT scores significantly 
predicted change in actual compliance performance over the four weeks for the 
young group, t (1, 29) = -2.15, p= .042, i= .27, R“= 24.80, part cor = -.381. 
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Again, no significant predictors emerged for the elderly group. 
Recall of the Medication Regimen 
To test hypotheses regarding accuracy of recall, participants were asked 
to rate how well they believed they could recall important information from the 
medication regimen (see Table 6). It was predicted that the young participants 
would attribute a higher rating to their ability to recall important medication 
information when compared with the elderly participants (see Table 6). No 
significant differences in ratings of recall were found between the two groups, t 
(2, 58)= 1.39, p = . 168, n.s.,r = .18. 
Additionally, young and older adults provided written answers to 
questions regarding the medication regimen. It was hypothesized that the 
young adults would show better recall of the medication information when 
compared with older adults. This hypothesis was supported, as the young 
group (M = 28.08) recalled more medication information in comparison to the 
elderly group (M = 24.17), t (2, 58) = 2.48, p = .016, r = .31. 
Discussion 
The purpose of the present study was to contrast young and older adults 
on self-reported and actual medication compliance. Research shows that older 
adults have difficulty remembering to take their medication as prescribed 
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(Isaac et al., 1993; Morrow et al., 1988). In addition, older adults have 
difficulty reporting to their physician how well they are complying with the 
medication regimen (Strecher et al. 1989; Rudd, 1990). Further exacerbating 
these problems is that older adults often follow complex medication regimens 
as they get older, while concurrently experiencing a decline in cognitive 
abilities (Park & Kidder, 1996). This study sought to answer the question ‘is 
the poor medication compliance demonstrated by elderly adults associated with 
declining cognitive abilities?” To investigate this question, young and older 
adults who were not presently taking any medication were recruited. This 
allowed for the implementation of a pseudomedication regimen, without the 
cognitive burden of remembering actual prescribed medications. The main 
focus of the study was to investigate the difference between the abilities of 
young and older adults to accurately rate and adhere to a complex, 
pseudomedication regimen for four weeks. Young adults served as a control 
group as their cognitive ability is presently at its peak. 
The major findings of this study were (a) the older adults did not differ 
from the young adults in their self-reported compliance ratings over the four- 
week period; (b) the older adults exhibited better compliance with the 
medication regimen when compared with the younger adults; and (c) the young 
Medication Compliance 
adults demonstrated superior cognitive performance when compared with older 
adults on event-based prospective memory, retrospective memory and speed of 
processing. These findings suggest that previous studies demonstrating the 
inability of older adults to follow complex medication regimens (Darnell et al., 
1986; Morrel et al., 1989) cannot be attributed solely to the declining cognitive 
abilities of older adults. 
Prospective Memory 
Young and older adults were compared on their ability to complete an 
event-based prospective memory task. As hypothesized, the young group 
demonstrated superior performance on this task. Although some research does 
support this finding (Cockbum & Smith, 1988; Dobbs & Rule, 1987), many 
studies fail to show age-related decrements in event-based prospective memory 
(Sinnot, 1986; West, 1988; Einstein & McDaniel, 1990). Because age-related 
deficits in prospective memory are attributed to a decline in self-initiated 
retrieval processes (Craik, 1986), it is possible that age decrements would not 
arise in event-based prospective memory. This is because event-based 
prospective memory requires little self-initiated retrieval, as the future action is 
performed only after an external cue (e g., a messy page, a specified word) 
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serves as a reminder. However, past studies may have been unable to find age 
differences in prospective memory because the retrospective portion of the task 
(e g., write one’s name) was too simple (Einstein et al., 1992). In the present 
study, the retrospective portion of the prospective task was multifaceted. 
Participants were required to remember to (1) tear out the messy page; (2) 
write their full name; (3) write the name of the questionnaire; and (4) list the 
relevant information in the top right-hand comer on the front of the page. 
Thus, in accordance with more recent analyses (Einstein et al., 1992; McDaniel 
& Einstein, 1992; McDaniel & Einstein, 1993), young adults performed better 
than older adults on event-based prospective memory tasks when the 
retrospective portion of the task is complex. 
Regarding time-based prospective memory, it was expected that young 
adults would perform better than older adults. However, no significant 
difference emerged between the two groups. Due to the high self-initiated 
retrieval processes involved in this task, age decrements in time-based 
prospective memory is a common finding (Einstein et al., 1995). However, the 
absence of a significant finding between young and elderly adults in the present 
study may result from the time-based occurring outside the laboratory. In the 
study, participants were asked to phone the lab on a specific day at a 
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predetermined time. It is possible that the lack of experimental control may 
have resulted in participants using an external cue (e g., reminder note) to 
prompt remembering. This would convert the task into a simple event-based 
prospective memory task, which past studies have failed to find age differences 
(West, 1988; Einstein & McDaniel, 1990). 
Retrospective Memory 
Young and older adults were compared on a retrospective memory task, 
called Subject-Performed Tasks (SPTs). SPTs were selected because they are 
an activity-specific retrospective memory task, which contains characteristics 
similar to the act of medication-taking. Contrary to the hypothesis, the young 
group performed better than the older adults on the retrospective memory task. 
Although age decrements in retrospective memory ability is a well-established 
finding (Hultsch & Dixon, 1990; Smith, 1996), the multimodal nature of SPTs 
could reduce age differences typically observed in free recall tasks (Backman, 
1985; Backman & Nilsson, 1985; Norris & West, 1993). However, this finding 
was not replicated in the present study, as a significant age-related difference in 
retrospective memory ability emerged. 
The young and elderly adults were compared on working memory 
ability. Contrary to the well-established finding that working memory declines 
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with age (Babcock & Salthouse, 1990; Dobbs & Rule, 1989; Salthouse, 1991), 
no group differences were found. This may have occurred because the 
processing aspect of the working memory task was insufficiently demanding. 
Prior studies demonstrating age differences in working memory ability have 
used measures with a more demanding processing task (Salthouse & Babcock, 
1991; Salthouse, 1991). For instance, Salthouse and Babcock (1991) used the 
Computation Span as a measure of working memoiy^. This measure requires 
the participant to answer arithmetic problems (the processing requirement), 
while simultaneously remembering the last digit in each problem (the storage 
requirement). In contrast, the Sentence Construction task was used in the 
present study. This task requires the participant to read the sentence aloud (the 
processing requirement), while remembering the underlined and capitalized 
word from the last sentence (the storage requirement). The processing 
requirement for the task in this study was evidently less demanding than the 
processing requirement used by Salthouse and Babcock (1991). Further 
exacerbating this problem is that recent studies have demonstrated that 
efficiency of processing speed is the major factor involved in age differences in 
working memory (Salthouse, 1992a; Salthouse & Kersten, 1993). 
As such, the young adults were expected to perfonn better than older 
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adults on a speed of processing task (the Digit Symbol). As expected, large 
age-related differences in speed of processing were found. This finding 
supports what is commonly reported in the literature (Babcock & Salthouse, 
1990; Morris, Gick & Craik, 1988; Salthouse, 1994). 
Predictors of Self-Reported Compliance 
To identify variables that may predict change in self-reported 
compliance over time, five memoiy variables (event-based prospective 
memory, time-based prospective memory, retrospective memory, working 
memoiy , and speed of processing) were entered into a multiple regression 
analysis. Event-based prospective memory emerged as the only significant 
predictor of change in self-reported compliance for the young adults. Event- 
based prospective memory involves remembering to perform a future action 
when a specific, external cue (e.g., a list) prompts remembering. Prospective 
memory is integral to successful medication-taking as one must remember to 
take medication in the future. Event-based prospective memory is involved in 
medication-taking when an individual makes a list or relates medication-taking 
to a certain event to remember to take their medication. To improve 
medication compliance, younger adults may have adopted such strategies as the 
four-week period progressed. Furthennore, event-based prospective memory 
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significantly predicts changes in self-reported compliance ratings for young 
adults, as it was found that this sample of younger adults performed better on 
an event-based prospective memory task when compared with older adults. 
No significant predictors of changes in self-reported compliance 
emerged for the elderly adults. It is possible that the strategies used by older 
adults did not change during the study. A second possibility is that other 
factors may have contributed to changes in self-reported compliance besides 
memory. Beliefs about one’s memory or types of strategy use may be potential 
factors of change in self-reported compliance ratings (Gould et al ., 1997). 
Predictors of Actual Compliance 
Five memory variables were identified as potential predictors of change 
in actual compliance over the four weeks. Event-based prospective memory, 
time-based prospective memory, retrospective memory, working memory, and 
speed of processing were entered into a multiple regression analysis. The only 
significant predictor of change in actual compliance for the young adults was 
retrospective memory. Retrospective memory involves memory for past events 
(e.g., remembering the name of a medication). Retrospective memory is 
integral to medication-taking as it allows the individual to monitor all of the 
medications in one’s regimen. Young adults may not have initially relied on 
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their retrospective memory abilities to remember how to take their medication 
correctly. Instead, young adults may have developed strategies based on their 
retrospective memory abilities (e.g., leave medication in a familiar spot) over 
the duration of the study. Additionally, the younger adults performed better on 
a retrospective memory task when contrasted with older adults. As such, it 
seems plausible that retrospective memory would emerge as a significant 
predictor for young adults as opposed to older adults. 
No significant memory variables emerged as predictors of change in 
actual compliance for the elderly adults. It could be that older adults used the 
same strategies for the four-week duration of the study. In addition, other 
factors could be responsible for predicting change in actual compliance. 
Different types of strategy use or beliefs about one’s memory could potentially 
influence change in actual compliance performance (Gould et al., 1997). 
Perceived Complexity 
It was anticipated that young adults would not find the regimen as 
complex when compared with older adults. Unexpectedly, the older adults did 
not find the regimen to be as complex as the younger adults did. The 
pseudomedication regimen was designed to be complex. Seven different 
medications were included in the regimen, while three of the medications were 
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to be taken four times daily. In addition, each medication had special 
instructions associated with it (e.g., take with food, take before bed). Several 
factors may account for the elderly group perceiving the regimen as less 
complex. The elderly group consisted of healthy older adults, who may be 
qualitatively different from elderly adults who are actually following complex 
medication regimens. Furthermore, the elderly sample included many 
educated, socially active participants. This may have resulted in a more 
motivated group. In contrast, young adults carrying a full university course- 
load may have been less motivated. Another possibility is that older adults 
may have used more external strategies (e.g., make a list and check off the 
medication used), which could have contributed to simplifying the medication 
regimen. 
Perceived Importance 
Perceptions of the study’s importance were compared for the young and 
older adults. Interestingly, older adults perceived the study as more important 
than younger adults. Because older adults are more likely to be taking 
prescribed medication, the study of medication compliance may seem more 
realistic to them, resulting in a more serious approach to the study. Also, the 
younger adults were maintaining a full course load during the study, which may 
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have resulted in a lower level of motivation due to time constraints. 
Self-Reported Compliance 
Group Differences in Change over time. It was hypothesized that young adults 
would show greater improvement in self-reported compliance scores when 
compared with the older adults over the four weeks. The young adults did not 
show significant improvement in self-reported compliance when compared 
with elderly adults. Since young adults are at the peak of their cognitive 
abilities, it was anticipated that they would rely on specific memory instances 
when monitoring their self-reported compliance performance over the four- 
week period. It was expected that the young adults increased familiarity with 
the task would result in greater improvement in self-reported compliance 
ratings when compared with older adults. However, since older adults did not 
experience greater improvement in self-reported compliance ratings, it is 
possible that other factors (e g., beliefs about one’s memory) may influence 
self-reported ratings. 
Group Differences in Self-Reported Compliance. It was expected that group 
differences would emerge between young and older adults in self-reported 
compliance ratings. Contrary to the hypothesis, young adults did not show 
higher self-reported compliance ratings. Again, it was expected that young 
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adults would rely on specific memory instances to achieve accurate self- 
reported compliance ratings. However, since young adults failed to show 
higher self-reported compliance ratings, it is possible that other factors (e.g., 
beliefs about one’s memory) may contribute to self-reported compliance 
ratings. 
Actual Compliance 
Group Differences in Change over time. The young group was expected to 
show greater improvement in actual compliance scores over the four-week 
period. However, they failed to show greater change in actual compliance 
scores when compared to older adults. Surprisingly, the elderly adults 
demonstrated better actual compliance performance. It was reasoned that 
young adults would achieve better compliance due to their superior cognitive 
abilities. However, it appears that change in actual compliance performance is 
not contingent on memory alone. Motivation may be an important factor 
influencing changes in compliance behaviour. The young adults were 
maintaining a full course load during the study, whereas older adults were 
retired. Thus, older adults may have had more time to contribute to the study. 
Further, the older group perceived the study as more important. This finding 
could result in greater improvement in actual compliance scores over the 
Medication Compliance 
duration of the study. Another possibility is that the older group may have 
relied on external strategy use to ease the cognitive burden of the medication 
regimen. 
Group differences in Actual Compliance. It was anticipated that young adults 
would show higher actual compliance scores when compared with the elderly 
group. Unexpectedly, older adults exhibited higher actual compliance scores. 
Again, it was reasoned that younger adults would have better compliance due 
to their superior cognitive abilities. However, it seems likely that other factors 
are important for successful medication compliance. As mentioned earlier, 
older adults were likely more motivated participants than younger adults. 
Additionally, older adults perceived the study as more important. Finally, older 
adults may have used more external strategies to assist in achieving optimal 
compliance. 
Relationship between Self-Reports and Actual Compliance 
Young and older adults were compared regarding the accuracy of their 
self-reported compliance. It was anticipated that both young and elderly adults 
would overestimate their self-reported compliance ratings. Contrary to the 
hypothesis, both groups did not overestimate their self-reported compliance 
ratings. Rather, the young and elderly adults significantly underestimated their 
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compliance when contrasted with actual compliance scores. Although the 
literature demonstrates that self-reports are often inaccurate (Roth, 1984; Park 
& Kidder, 1996), it is typically found that self-reported compliance is 
overestimated (Rudd, 1990; Spector et al., 1986). A possible explanation for 
this outcome is that young adults may have been aware that they lacked 
motivation. As a result, their actual compliance performance could have been 
better. As such, they have attributed a lower self-reported compliance rating 
than otherwise might be expected. Older adults may have simply casually 
estimated their ratings. For instance, a total of 133 medication mistakes could 
have been committed each week. If an older adult is contemplating their rating 
and figures that they missed approximately six medications, they might 
casually attribute a rating of 90% to their compliance, when in actuality their 
compliance rating is above 95%. Thus, older adults may have been unaware 
that missing 5 or 6 medications would still leave them with a rating of 95% or 
more. 
Recall of the Medication Regimen 
Next, the young and elderly were compared regarding their perceived 
recall of important medication information from the regimen. Contrary to the 
hypothesis, the younger adults did not attribute higher rating to their perceived 
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recall of medication information when compared with the older adults. 
Because younger adults are at the peak of this long-term memory ability, it was 
anticipated that the younger adults would attribute a higher rating to their 
perceived recall of the medication information. Again, it is possible that the 
young adults were aware that they did not perform optimally when following 
the medication regimen. As such, young adults may have felt that the important 
medication information from the regimen was not encoded very well in their 
memory. 
For the final hypothesis, it was anticipated that the young group would 
show better actual recall of the medication regimen when compared with the 
elderly group. As expected, large age-related differences existed regarding the 
actual recall of the medication information. Not surprisingly, the young group 
demonstrated better performance in the actual recall of the medications as it is 
a long-term memory task. It is well-established in the literature that young 
adults are superior to elderly adults in long-term memory ability (Light & 
Anderson, 1983; Albert et al., 1988; Salthouse & Mitchell, 1989). 
Limitations 
A limitation of this study is that the young and older adults samples 
may not be representative of the typical younger and older adult populations. 
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The young adults in this study were first-year university students. Thus, they 
may be higher functioning or more motivated to participate in a research study 
than non-university students. The sample of older adults in the study were 
healthy, older adults not using any prescribed medications. Personal 
information provided by the elderly adults suggested that they may be more 
educated and possibly lead more active lives than other older adults. The older 
adults claimed that they were socially active in the community at least three 
days a week. Thus, they may have been more motivated to volunteer to 
participate in a demanding four-week study. 
The duration of this study may also have been a limitation. As the study 
was only four weeks in length, it is possible that medication compliance could 
improve or deteriorate over time. A longer study may provide different results 
than this study did. 
The use of sealed medication bottles to record medication-taking may 
have produced a technical limitation to this study. Although the medication lid 
had a tape seal, the participant could remove the tape and count the number of 
medications they had taken. It was stressed to the participant that the results 
should be honest and accurate. However, ensuring that participants would not 
look inside the medication bottles was not possible. A better method of 
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recording medication compliance would be to use the Medication Event 
Monitoring System (MEMS). This system involves using medication bottles 
with a microchip hidden in the medication lid. Thus, whenever the participant 
removes the lid to take a medication, the date and time of the occurrence is 
recorded. This system clearly provides a superior method of recording 
medication adherence. However, it is expensive and beyond the budget allotted 
for this study. 
A further limitation to this study was asking participants to use their 
imaginations to pretend that they were afflicted with five different medical 
problems. In addition, they were asked to keep track of seven medications and 
pretend that they were really taking them. The participants were informed that 
missing or taking too many medications would adversely affect their health. 
Unfortunately, monitoring the participants’ use and effectiveness of their 
imagination was not possible. As such, this study would be more reliable if the 
participants were actually taking the medications. 
A final limitation to this study is that a cross-sectional design was used. 
As mentioned earlier, age-related differences emerging from cross-sectional 
studies may be exaggerated due to cohort effects (Schaie, 1988). The use of a 
longitudinal study in which participants are tested at specified ages, and 
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assessed at regular intervals would have improved the internal validity of the 
study (Schaie, 1988). 
Directions for Future Research 
Future investigations may strengthen the findings of this study by 
following participants for a longer period. It is uncertain whether four weeks is 
sufficient time for a clear medication-taking pattern to emerge. Recording 
medication-taking behaviour over several months may show patterns of 
compliance improvement or decline. Furthermore, the use of a MEMS 
recording device in future studies would contribute greatly to the recording 
accuracy of actual medication compliance. 
The present study has established that healthy older adults (i.e., those 
not taking any prescribed medications) possess the ability to adhere to a 
complex pseudomedication regimen. However, a study is needed that would 
contrast medication-taking older adults with older adults who are not taking 
prescribed medications. Such a study could contrast the two groups on factors 
that may influence medication-taking behaviour. For instance, a study could be 
conducted to observe if group differences exist in different types of memory, 
level of social activity, general cognitive functioning, lifestyle factors (e.g., 
diet, alcohol use), alertness, medication-taking strategy use, etc. 
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Conclusion 
According to past findings, the present study has demonstrated that 
younger adults generally exhibit superior performance in memory abilities 
involved in medication-taking (Park & Kidder, 1996). Growth curve analyses 
revealed differences regarding self-reported ratings. However, older adults 
demonstrated better actual compliance performance in comparison to young 
adults. As such, it appears that the declining cognitive abilities of older adults 
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Procedures to be Followed 
Procedures to be followed 
MEDICATION COMPLIANCE 
Purpose of the study; 
The purpose of this study is to examine the medication-taking behaviours of introductory 
psychology students and older adults when placed on a pseudo-medication regimen for 4 weeks. 
This regimen is designed to reflect that of a typical older adult. 
Procedures to be followed 
During this study you will be asked to; 
1. tell us about your age, educational background, mood, and health status 
2. complete some memory questionnaires and answer some questions about your 
memor>' 
3. follow a pseudo-medication regimen for 4 weeks 
4. answer a few questions each week about the pseudomedication regimen 
Time Required 
Your participation will consist of 5 visits. 
1. An Initial Interview lasting 1-1.5 hours. (Week 1) 
2. Two telephone interviews approximately 30 minutes in length. (Weeks 2 and 4) 
3. A home visit lasting about 30 minutes. (Week 3) 
4. A Final Interview lasting approximately 45 minutes. (Week 5) 
Risks and Benefits 
Being asked to perform a task or take a test can sometimes be a stressful experience. It 
is, however, through the cooperation of individuals such as yourself that we with interests in 
Life-Span Developmental Psychology are able to understand how adults learn and remember. 
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Appendix 2 
Informed Consent Form 
LAKEHEAD UNIVERSITY 
INFORMED CONSENT FORM 
Title of the Investigation: MEDICATION COMPLIANCE 
Investigators: Leslie McDonald-Miszczak, Ph.D 
Trevor Sullivan, M.A. Program 
This is to certify that I, hereby agree 
to participate as a volunteer in a scientific study as an authorized part of the educational research 
program at Lakehead University. 
The study and my part in it have been defined by the investigator and I understand the 
summary. The procedures of this study are described on the first page of this form and have 
been presented in detail. 
I have been given the opportunity to ask whatever questions I may have had and all such 
questions and inquiries have been answered to my satisfaction. 
I understand that I am free to refuse to participate in any specific task or to refuse to 
answer any specific test questions. 
I understand that any data or answers to questions will remain confidential with regard to 
my identity. 
I understand that my data will be stored in a locked laboratory and participants will be 
informed that their data must remain on location at Lakehead University for a period of seven 
years. 
I certify that to the best of my knowledge and beliefs, I have no physical illness or other 
problem that would increase the risk to me due to participation in this study. 
I FURTHER UNDERSTAND THAT I AM FREE TO WITHDRAW MY 
CONSENT AND TERMINATE MY PARTICIPATION AT ANY TIME. 
Date:  Signature of  
Participant 
I, the undersigned, have defined and fully explained the above to the participant in detail, 
and to my best knowledge and belief it was understood. 
Date:  Signature of 
Investigator 
Medication Compliance 92 
Appendix 3 
Event-Based Prospective Memory Task 
Event-Based Prospective Memory Task 
Note: this task is to be presented at the beginning of the Initial Interview. 
The first questionnaire that I’ll ask you to complete is the Personal Information 
Questionnaire. This questionnaire asks you a few questions regarding your age, educational 
background, health status, and so on. When you are completing this questionnaire or one of the 
other questionnaires that I will be giving you today, you may notice that the odd page is very 
messy and difficult to read. Lately. I have been getting the occasional messy page from the Print 
Shop. I guess they must be having trouble with dieir photocopiers. Anyhow, I checked through 
your questionnaires for messy pages and I think I got them all. But if I didn’t, I was wondering if 
you could do me a favour? If you come across a messy page in one of the questionnaires, could 
you pull the page out of the booklet and write the name of the questionnaire from which you 
pulled the messy page, in the top right-hand comer? Thanks for your help. 
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Personal Information Questionnaire 
PERSONAL INFORMATION SHEET 
ID 
In order to better understand the results of our study, we need to know a few things about you 
and your background. This information will be used for research purposes and it will be kept 
strictly confidential. 
1. My birth date is:  
(day) (month) (year) 
2. My gender is: 
a. male 
b. female 






f common-law relationship 
4. How old do you feel mentally? years 
5. How old do you feel physically? years 
6. Who else lives in your home? (circle all that apply) 
a. my spouse 
b. my adult son or daughter 
c. one or more children 
d. I live alone 
e. other (please specify)  
7. How often do you engage in social activities such as visiting friends at their house, eating at 
restaurants, attending musical performances, and other similar activities? 
a. less than once a month 
b. 1 - 2 times a month 
c. 1 - 2 times a week 
d. more than 3 times a week 
8. How often do you have wine, beer or other alcoholic drinks? 
a. about once a day 
b. 1-2 times a week 
c. 2 - 3 times a month 
d. about once a month 
e. several times a year 
f. about once a year or less 
g. never 
9. When you have alcoholic beverages, how much do you have? 
a. I never drink alcoholic beverages 
b. 1 - 2 drinks 
c. 3 - 4 drinks 
d. 5 - 6 drinks 
e. more than six drinks 
10. Please indicate the level of education that you have completed: 
Primary 1 2 3 4 5 6 7 8 
Secondary 9 10 11 12 13 
College 12 3 4 
University 123456789 
Trade School 12 3 4 
11. Currently, I am (please circle all that apply) 
a. employed full-time 
b. employed part-time 
c. retired 
d. full-time homemaker 
e. part-time homemaker 
f doing volunteer work 
g. a full-time student 
h. a part-time student 
I. other (please specify)  
THE FOLLOWING ARE A FEW QUESTIONS ABOUT YOUR GENERAL HEALTH: 
12. Compared to a perfect state of health, I believe my overall health to be (please circle one): 




e. very poor 
13. Compared to other people my age, I believe my overall health to be (please circle one): 




e. very poor 
14. I use the following corrective lenses for my eyesight: 
a. I don’t use glasses or contact lenses 
b. glasses or contact lenses for distances 
c. glasses or contact lenses for reading or close work 
15. Do you require a hearing aid? 
a. yes 
b. no 
16. How many times have you visited your doctor in the past 12 months? 
a. none 
b. once 
c. 2 - 5 times 
d. 6-12 times 
e. over 12 times 
17. How many nights have you spent in a hospital or nursing home during the last 12 months? 
a. none 
b. 1-6 nights 
c. 1 - 3 weeks 
d. 1 month or more 
18. Please indicate which medical conditions you have experienced in the last five years (circle 













m. heart disease 
n. hepatitis 
o. high blood pressure 
p. influenza 
q. kidney disease 
r. multiple sclerosis 
s. Parkinson’s disease 
t. pneumonia 
u. polio effects 
V. thyroid disease 
w. tuberculosis 
X. stroke or effects of stroke 
y. ulcers 
z. other (please specify)  
19. Have you had the following surgeries during the last 5 years? (circle all that apply) 
a. appendectomy 
b. back surgery 
c. endarterectomy/carotid surgeiy' (to clear the arteries in the neck) 
d. gallbladder surgery 
e. hernia repair 
f hysterectomy 
g. mastectomy 
h. open heart surgery 
I. prostate surgery 
j. tonsillectomy 
20. How many different medications has your doctor prescribed to you in the last two years 
a. none 
b. 1 - 2 different medications 
c. 3 - 4 different medications 
d. 5 - 6 different medications 
e. 7 or more different medications 
21. How many different prescribed medications are you taking now? 
a. none 
b. 1 - 2 different medications 
c. 3 - 4 different medications 
d. 5 - 6 different medications 
e. 7 or more different medications 
Appendix 5 
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The Centere for Eoidemiolosical Studies - Depression Scale 
Mood Questionnaire 
Zn this booklet, there are statements about the vay that most 
people feel at one time or another. There is no such thing as a 
"right** or "wrong** answers, because people are different. All you 
have to do is answer the statements according to how you have felt 
during the past week. Don't answer according to how you usually 
feel, but rather how you have felt during the past week. Each 
statement is followed by four choices. Mark a circle around the 
letter corresponding to your choice. Mark only one letter for each 
statement. For example: 
During the past week, Z was happy. 
a. Barely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
Zn the example, you could, of course, choose any one of the 
answers. Zf you felt really happy, you would choose and circle d. 
Zf you felt very unhappy you would circle a. The b and c answers 
give you middle choices. 
Keep these points in mind: 
1. Don't spend too much time thinking about your answer. Give the 
first natural answer as it comes to you. 
2. Answer every question, even if it doesn't seem to apply to you 
very well. 
3. Answer as honestly as you can what is true/of you. Please do 
not mark something because it seems like "the right thing to say". 
1 
1. During the past veek Z was bothered by things that usually don't 
bother me. 
a. Barely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
e. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5 - 7 days) 
2. During the past veek I did not feel like eating; my appetite was 
poor. 
a. Barely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
e. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
3. During the past veek 1 felt that Z could not shake off the blues 
even with help from my family or friends. 
a. Barely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
4. During the past veek Z felt that Z vas just as good as other 
people. 
a. Barely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
5. During the past veek Z bad trouble keeping my mind on vhat Z vas 
doing. 
a. Barely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5 7 days) 
6. During the past veek Z felt depressed. 
a. Barely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
e. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
2 
7. During the past veeX I felt that averything X did was an effort. 
a. Karely or none of the time (less than one a day) 
b. Some or a little of the tine (1-2 days) 
c. Occasionally or a noderate amount of time (3-4 days) 
d. Most or all of the tine (5-7 days) 
8. During the past veeX I felt hopeful about the future. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
9. During the past veek I thought my life had been a failure. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
10. During the past veek I felt fearful. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
11. During the past veek my sleep vas restless. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
12. During the past veek I vas happy. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c* Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5 - 7 days) 
13. During the past veek I talked less than usual. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
e. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
3 
14. During the past veeX 1 felt lonely. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
e. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
15. During the past veeX people vere unfriendly. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
16. During the past veeX I enjoyed life. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
17. During the past veeX 2 had crying spells. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
18. During the past veeX Z felt sad. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
19. During the past veeX Z felt that people disliXe me. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of.the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
20. During the past veeX Z eould not get **going**. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of time (3-4 days) 
d. Most or all of the time (5-7 days) 
4 
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Metamemory in Adulthood Questionnaire 
Memory Questionnaire 
Directions 
Different people use their memory in different ways in their everyday lives. For 
example, some people make shopping lists, whereas others do not. Some people are good at 
remembering names, whereas others are not. 
In this questionnaire, we would like you to tell us how you use your memory and how 
you feel about it. There are no right or wrong answers to these questions because people are 
different. Please take your time and answer each of these questions to the best of your ability. 
Each question is followed by five choices. Draw a circle around the letter corresponding 
to your choice. Mark only one letter for each statement. 
Some of the questions ask your opinion about memory-related statements; for example; 
My memory will get worse as 
1 get older. 




e. disagree strongly 
In this example you could, of course, choose any one of the answers. If you agree strongly with 
the statement, you would circle a. If you disagree strongly, you would circle letter e. The b and 
d answers indicate less strong agreement or disagreement. The letter c answer gives you a 
middle choice, but don't use the c unless you really can’t decide on any of the other responses. 
Some of the questions ask how often you do certain things that may be related to your 
memory. For example; 
Do you make a list of things 







Again, you could choose any one of the answers. Choose the one that comes closest to what you 
usually do. Don’t worry if die time estimate is not exact, or if there are some exceptions. 
Keep these points in mind; 
(a) Answer every question, even if it doesn’t seem to apply to you very well. 
(b) Answer as honestly as you can what is true for you. Please do not mark something because 
it seems like the “right thing to say.” 
1. lam good at remembering 
names. 




e. disagree strongly 
2. Do you keep a list or 
otherwise note important 







3. I get upset when I cannot 
remember something. 




e. disagree strongly 
When you are looking for 
something you have 
recently misplaced, do 
you try to retrace your 







5. I find it harder to 
remember things when I am 
upset. 




e. disagree strongly 
I am good at remembering 
birthdays. 




e. disagree strongly 
7. When you have not 
finished reading a book 
or magazine, do you 
somehow note the place 






8. I get anxious when I am 
asked to remember 
something. 




e. disagree strongly 
I have difficulty 
remembering things when I 
am anxious. 




e. disagree strongly 
10. Do you think about the 
day’s activities at the 
beginning of the day so 
you can remember what you 






111 have no trouble keeping 
track of my appointments. 




e. disagree strongly 
12.1 am usually uneasy when 
I attempt a problem that 
requires me to use my 
memory. 




e. disagree strongly 
13.1 feel jittery if I have 
to introduce someone I 
just met. 




e. disagree strongly 
14. Do you post reminders of 
things you need to do in 
a prominent place, such 







15.1 am poor at remembering 
trivia. 




e. disagree strongly 
16. Do you routinely keep 
things in a familiar spot 
so you won’t forget them 







17. When you want to take 
something with you, do 
you leave it in an 
obvious, prominent place, 
such as putting your 







18. If 1 am put on the spot 
to remember names, I know 
I will have difficulty 
doing it. 




e. disagree strongly 
19. When you try to remember 
people you have met, do 







20.1 am good at remembering 
the order that events 
occurred. 




e. disagree strongly 
21.1 am good at remembering 
conversations I have had. 




e. disagree strongly 
22.1 would feel on edge 
right now if I had to 
take a memory test or 
something similar. 




e. disagree strongly 
23. When you have trouble 
remembering something, do 
you try to remember 
something similar in 







24.1 often forget who was 
with me at events I have 
attended. 




e. disagree strongly 
25. Do you consciously 
attempt to reconstruct 
the day’s events in order 






26. lam good at remembering 
the places I have been. 




e. disagree strongly 
27. Do you try to relate 
something you want to 
remember to something 
else hoping that this 
will increase the 







28. When I am tense and 
uneasy at a social 
gathering, I cannot 
remember names very well. 




e. disagree strongly 
29. Do you try to concentrate 
hard on something you 






30. When someone I don’t know 
very well asks me to 
remember something, I get 
nervous. 




e. disagree strongly 
31.1 have no trouble 
remembering where 1 have 
put things. 




e. disagree strongly 
32. Do you make mental images 







33.1 am good at remembering 
things like recipes. 




e. disagree strongly 
34.1 get anxious when I have 
to do something I haven’t 
done for a long time. 




e. disagree strongly 
35. Do you mentally repeat 







36.1 get tense and anxious 
when 1 feel my memory is 
not as good as other 
peoples’. 




e. disagree strongly 
37. Do you ask other people 







38.1 do not get flustered 
when I am put on the spot 
to remember new things. 




e. disagree strongly 
39. I am as good at remembering 
titles of books, films 
and plays. 




e. disagree strongly 
40.1 have no trouble 
remembering lyrics 
of songs. 




e. disagree strongly 







42.1 am good at remembering 
names of musical 
selections. 




e. disagree strongly 
43. After I read a book, I 
have no difficulty 
remembering factual 
information from it. 




e. disagree strongly 
44. Do you write appointments 







45.1 would feel very anxious 
if I visited a new place 
and had to remember how 
to find my way back. 




e. disagree strongly 
46.1 am good at remembering 
the content of news 
articles and broadcasts. 




e. disagree strongly 
47. Remembering the plots of 
stories and novels is 
easy for me. 




e. disagree strongly 
48.1 am usually able to 
remember exactly where I 
read or heard a specific 
thing. 




e. disagree strongly 









The Digit Symbol Subtest of the Wechsler Adult Intelligence Scale - Revised 
Digit Symbol Instructions 
For this task, you are required to match the appropriate symbol with the appropriate 
number. For example, in the “samples” section, you are given 7 numbers with each number 
being assigned a specific symbol. For the number 2, you would write this symbol (point to the 
appropriate symbol) in the box below it. For number 1, you would write this symbol (point to 
the appropriate symbol) in the box below. Please continue with the remainder of the sample 
examples, so you can become better acquainted with the task. When you have completed the 
“samples” section, you will have 90 seconds in which to complete as much of the task as 
possible. 
Note: Use a stopwatch to time the task 
Digit Symbol—Coding 
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Appendix 8 
Sentence Construction Task 
Working Memory Task Instructions 
For the following task. I’ll be presenting sentences one at a time and asking you to read 
them aloud at your normal reading pace. One of the words in each sentence is printed in all 
capital letters and underlined. For the set of sentences these words will form a new sentence. 
These sentences are contained in this binder. I will be presenting these sentences one at a time 
and flipping to the next page when you have completed reading the sentence. At the end of a set 
of sentences, I will ask you to report the new sentence. Note: open the binder to the first 
example sentence. For example, I would like you to read the example sentence and take note of 
the word that is underlined and printed in capital letters. Note: when the participant has 
finished reading the sentence, flip the page and move on to the next example sentence. Next, 
I would like you to read this sentence and once again be sure to pay special attention to the word 
that is underlined and printed in capital letters. When you see the blank page, tell me the short 
sentence that the two underlined words form? Let’s try another one. This next example will be 
3 words long (Note: do example). The remainder of the task will follow this format as 1 v^ll 
present a group of sentences, one sentence at a time. The sentences will gradually get longer as 
we proceed. At the end of a set of sentences, you will see a blank page and I will ask you to 
report the new sentence. Any questions? Are you ready to begin? 
Note: If the participant misses 2 sets of sentences within a set, terminate the task. 
Working Memory Sentences 
Note: Words in upper case and underlined form sentences. 
She was a GOOD baby. 
He relied on his LUCK. 
THE words on the page were printed in red ink. 
The MAN gave his wife a ring as a Christmas gift. 
Their antique chair broke when the guest SAT on it. 
THE filing cabinet was stuffed with so much paper that it could not be closed. 
The BIRD flew out of her nest to fetch some food for her young. 
The pond FROZE solid during the cold snap in Janua^y^ 
SHE picked up the needles and began to knit the sweater. 
The deer RAN across the meadow toward the safety of the woods. 
The car was going very FAST when it left the road and hit the tree. 
THE boat left the dock and headed out into the calm water. 
On top of the hill stood the tallest TREE he had ever seen. 
He FELL off his bicycle and scraped his knee badly. 
SHE could hardly tie her shoelace because her hands were trembling so. 
The swarm of bees CHASED the children who had broken the hive. 
THE girls talked for hours and hours before they fell asleep. 
The player dropped the BALL even though it was thrown right to him. 
The calendar on the wall showed that it was THE first day of March. 
The DOG guarded the house while his owners were away on holidays. 
The forecaster predicted that it WAS going to be a cold winter. 
The sea lions began BARKING as soon as they finished their trick. 
The day was so windy that the sailor decided to return to THE harbor. 
A clown handed candy to the young CHILDREN during the parade. 
He WATCHED the ducks fly to the shallow pond. 
The beer parlor served draft by THE glass or mug. 
The CHIPMUNKS gathered food for the winter and hid it in a tree. 
The breeze blowing off the blue ocean was FRESH and cool. 
She put the VEGETABLES in the boiling water along with a little salt. 
Television programs today ARE different than those of twenty years ago. 
It was a VERY warm day for the middle of December. 
The oysters served on their shells with hot sauce were TASTY. 
THE hawk circled his prey several times before diving to capture it. 
The DOCTOR was over eighty years old when he retired from practice. 
The postman DELIVERED the large package to the house. 
When shifting gears you have to remember to depress THE clutch. 
The BABY cried all night because her new teeth hurt. 
The army recruits were required to POLICE the grounds before dinner. 
The robber was ARRESTED only two blocks from the holdup scene. 
The child played with the rubber duck while his mother gave HIM a bath. 
The party resumed in the garden AFTER being interrupted by the shower. 
THE cup of hot coffee burned his lips. 
The two butlers gossiped about the MURDERS that had occurred. 
The play is a clever comedy which kept THE audience laughing heartily. 
The little HORSE stood under the maple tree near the fence. 
The skier INJURED his back when he fell on the ski hill. 
The woman took HER car to the garage to have it repaired. 
The cat sharpened her claws on the LEG of the table scarring it deeply. 
The twins celebrated their fourth birthday YESTERDAY. 
THE kittens were six weeks old when they were sold. 
The SECRETARY sat at her desk smoking a cigarette. 
The professor REMAINED after class to answer additional questions. 
The dentist fitted the bridge W the patient’s mouth. 
The lovely music on the radio encouraged THE couple to dance. 
The OFFICE was located in a large building near the center of town. 






The man sat. 
Items 
1.  
The bird froze 
2.  
She ran fast 
3.   
The tree fell 
4.  
She chased the ball 
5.   
The dog was barking 
6.  
The children watched the chipmunks 
7.  
Fresh vegetables are very tasty 
8.   
The doctor delivered the baby 
9.  
Police arrested him after the murders 
10.   
The horse injured her leg yesterday 
11.   
The secretary remained in the office 
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Subject-Performed Task 
Subject Performed Task (SPT) Instructions 
For this task. I’ll be presenting a list of 35 action pairs. An “action-pair” involves two 
words presented together as a pair which describe a particular action. For example “shuffle- 
cards”, “pinch-wrist”, or “push-box”. 1 will be presenting these action pairs verbally, one at a 
time. After 1 present each action pair to you, I want you to perform the action that I’ve described 
in the action pair. Note: do several examples to ensure that the participant understands the 
procedure. After 1 have presented the 35 action pairs, you will be given 7 minutes to recall as 
many action pairs as possible. How many action pairs do you think you’ll be able to recall? 
Note: Present the 35 action pairs followed by the relevant sheet for the free recall 
procedure. 
Note: the same 35 action-pairs will be presented in two additional trials. Also, a global 
prediction regarding their recall will be made prior to presentation of the action pairs. 
Note: Write Global Prediction at the bottom of the Digit Symbol Task. 




































SPT Word Pairs 
In the spapes below, please write down as many word-pairs as you can remember firpm 
the list you have just hear^j. You may write down the word-pairs in any you wisp. You 



























Knowledge of Medication Questionnaire 
ID  
Knowledge of Medication Questionnaire (Adalat) 
Note: if participant has knowledge of medication, investigate farther. 
1. Have you ever heard of a medication called Adalat? 
(Yes / No) 
2. Do you know what this medication is designed to treat? 
(Yes / No) 
3a. Do you have knowledge of hypertensive medication? 
(Yes / No) 
b. If so, what do you know about hypertensive medication (re; names of hypertensive 
medications and a description of hypertensive medications)? 
Note: Ask questions 4-7 for each hypertensive medication that the participant states. 
4. Do you know how many times daily this medication is to be taken? 
(Yes / No) 
5. Do you know the amount of medication that is to be taken daily? 
(Yes / No) 
6. Do you know whether or not this medication is to be taken in conjunction with another 
medication? 
(Yes / No) 
7. Do you know the context (i.e. with food, on an empty stomach, etc.) in which this medication 
is to be taken? 
(Yes / No) 
8. Do you know the side effects associated with this medication? 
(Yes / No) 
ID_  
Knowledge of Medication Questionnaire (Diltiazem) 
Note: if participant has knowledge of medication, investigate further. 
1 Have you ever heard of a medication called Diltiazem? 
(Yes / No) 
2. Do you know what this medication is designed to treat? 
(Yes / No) 
3a. Do you have knowledge of cardiovascular medication? 
(Yes / No) 
b. If so, what do you know about cardiovascular medication (re: names of cardiovascular 
medications and a description of cardiovascular medications)? 
Note: Ask questions 4 - 7 for each cardiovascular medication that the participant states. 
4. Do you know how many times daily this medication is to be taken? 
(Yes / No) 
5. Do you know the amount of medication that is to be taken daily? 
(Yes / No) 
6. Do you know whether or not this medication is to be taken in conjunction with another 
medication? 
(Yes / No) 
7. Do you know the context (i.e. with food, on an empty stomach, etc.) in \^ch this medication 
is to be taken? 
(Yes / No) 
8. Do you know the side effects associated with this medication? 
(Yes / No) 
ID  
Knowledge of Medication Questionnaire (Calcium) 
Note: if participant has knowledge of medication, investigate further. 
1. Have you ever heard of Calcium? 
(Yes / No) 
2. Do you know what Calcium is designed to treat? 
(Yes / No) 
3a. Do you have knowledge of medication designed to treat Osteoporosis? 
(Yes / No) 
b. If so, what do you know about cardiovascular medication (re: names of medications 
designed to treat Osteoporosis and a description of Osteoporosis medications)? 
Note: Ask questions 4 - 7 for each Osteoporosis medication that the participant states. 
4. Do you know how many times daily this medication is to be taken? 
(Yes / No) 
5. Do you know the amount of medication that is to be taken daily? 
(Yes / No) 
6. Do you know whether or not this medication is to be taken in conjunction with another 
medication? 
(Yes / No) 
7. Do you know the context (i.e. with food, on an empty stomach, etc.) in which this medication 
is to be taken? 
(Yes / No) 
8. Do you know the side effects associated with this medication? 
(Yes / No) 
ID  
Knowledge of Medication Questionnaire (Vitamin D") 
Note: if participant has knowledge of medication, investigate further. 
1. Have you ever heard of Vitamin D? 
(Yes / No) 
2. Do you know what Vitamin D is designed to treat? 
(Yes / No) 
3a. Do you have knowledge of medication which is essential for bone maintenance? 
(Yes / No) 
b. If so, what do you know about medication which is essential fcM* bone maintenance (re: 
names of medications which are essential for bone maintenance and a description of bone 
maintenance medications)? 
Note: Ask questions 4 - 7 for each bone maintenance medication that the participant states. 
4. Do you know how many times daily this medication is to be taken? 
(Yes / No) 
5. Do you know the amount of medication that is to be taken daily? 
(Yes / No) 
6. Do you know whether or not this medication is to be taken in conjunction with another 
medication? 
(Yes / No) 
7. Do you know the context (i.e. with food, on an empty stomach, etc.) in which this medication 
is to be taken? 
(Yes / No) 
8. Do you know the side effects associated with this medication? 
(Yes / No) 
ID  
Knowledge of Medication Questionnaire (RestoriH 
Note: if participant has knowledge of medication, investigate further. 
1. Have you ever heard of a medication called Restoril 
(Yes / No) 
2. Do you know what this medication is designed to treat? 
(Yes / No) 
3a. Do you have knowledge of insomnia medication? 
(Yes / No) 
b. If so, what do you know about insomnia medication (re: names of insomnia medications and 
a description of insomnia medications)? 
Note: Ask questions 4 - 7 for each insomnia medication that the participant states. 
4. Do you know how many times daily this medication is to be taken? 
(Yes / No) 
5. Do you know the amount of medication that is to be taken daily? 
(Yes / No) 
6. Do you know whether or not this medication is to be taken in conjunction with another 
medication? 
(Yes / No) 
7. Do you know the context (i.e. with food, on an empty stomach, etc.) in which this medication 
is to be taken? 
(Yes / No) 
8. Do you know the side effects associated with this medication? 
(Yes / No) 
ID  
Knowledge of Medication Questionnaire (Ventolin) 
Note: if participant has knowledge of medication, investigate further. 
1. Have you ever heard of a medication called Ventolin? 
(Yes / No) 
2. Do you know what this medication is designed to treat? 
(Yes / No) 
3a. Do you have knowledge of pulmonary medication? 
(Yes / No) 
b. If so, what do you know about pulmonary medication (re: names of pulmonary medications 
and a description of pulmonary medications)? 
Note: Ask questions 4 - 7 for each pulmonary medication that the participant states. 
4. Do you know how many times daily this medication is to be taken? 
(Yes / No) 
5. Do you know the amount of medication that is to be taken daily? 
(Yes / No) 
6. Do you know whether or not this medication is to be taken in conjunction with another 
medication? 
(Yes / No) 
7. Do you know the context (i.e. with food, on an empty stomach, etc.) in which this medication 
is to be taken? 
(Yes / No) 
8. Do you know the side effects associated with this medication? 
(Yes / No) 
ID  
Knowledge of Medication Questionnaire (Atrovent') 
Note: if participant has knowledge of medication, investigate further. 
1. Have you ever heard of a medication called Atrovent? 
(Yes / No) 
2. Do you know what this medication is designed to treat? 
(Yes / No) 
3. Do you know how many times daily this medication is to be taken? 
(Yes / No) 
4. Do you know the amount of medication that is to be taken daily? 
(Yes / No) 
5. Do you know >^diether or not this medication is to be taken in conjunction with another 
medication? 
(Yes / No) 
6. Do you know the context (i.e. with food, on an empty stomach, etc.) in which this medication 
is to be taken? 
(Yes / No) 
7. Do you know the side effects associated with this medication? 
(Yes / No) 
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Experimenter’s Script for Initial Visit 
Initial Visit 
As you know. I’ll be conducting this study over the next 4 weeks. First of all, I would 
like to thank you for your participation in this study. Without volunteers such as yourself, it 
would be virtually impossible to conduct research examining medication-taking behaviours. 
Please feel free to ask any questions at any time during the session and I’ll do my best to answer 
them for you. As I mentioned earlier, this study will be conducted for a total of 4 weeks. The 
purpose of this study is to simulate a medication regimen that is commonly prescribed for ill 
older adults. We are interested in how healthy younger and older adults find the experience of 
trying to adhere to this type of regimen. Before we begin. I’d like to ask you a few questions 
about the medications used in this study (Note: Ask Knowledge of Medications Questionnaire). 
Because of the nature of this study, it is paramount that this study mimic reality. 
Therefore, it is crucial that you and I maintain a pharmacist/patient style relationship. This will 
involve some imagination on your part as you will be taking one or more simulated medications 
for several imaginary’ illnesses. 
Over the course of this study, you will be required to follow a simulated daily medication 
regimen. You will be asked to keep track of your “medications” using these pill bottles 
containing beads (Note: hold up containers). We will meet in person or talk on the telephone 
every week at a prearranged time in order for you to (a) answer a few questions about your 
medication-taking behaviours and (b) receive refills of your simulated medications. It is verv' 
important that you keep all of your pill bottles and used “medications”. At the beginning of each 
week, you will start using newly filled bottles which will replace the used ones. Now it is very 
important for you to remember that you won’t be asked to ingest any medications of any kind. 
You will simply be asked to keep track of these beads as if you were taking them as medication 
During the final meeting, at the end of the 4 week period, you will be asked a final set of 
questions about your medication-taking behaviours and will return all of the pill bottles and 
unused beads at that time. 
The imaginary illnesses that you will be suffering fi'om are Hypertension (high blood 
pressure). Cardiovascular Disease (heart problem). Osteoporosis (weak bones). Pulmonary 
Disorder (breathing problem), and Insomnia (trouble sleeping). It is essential to remember that 
you have the aforementioned problems and that it is important for you to take each medication, 
in the correct dosage and context, and at the correct time. However, before I begin to describe 
the medication scenario that you will be following. I’d like to take a moment to once again 
review the imaginary illnesses that you will be afflicted with. These include; Hypertension 
(high blood pressure). Cardiovascular Disease (heart problem). Osteoporosis (weak bones), 
Pulmonary Disorder (breathing problem), and Insomnia (trouble sleeping). 
The Medication Scenario 
Your medication regimen will consist of a total of 7 medications. 
1. For your hypertension (high blood pressure) problem, you will be taking a medication called 
Adalat. The purpose of this drug is simply to reduce your high blood pressure and although this 
condition usually has no apparent symptoms, it is important that you continue to take your 
medication as prescribed. You should take one tablet twice daily, preferably at the same two 
times each day. Adalat should be taken with food. The first time you take this medication, you 
may feel slightly hotheaded and dizzy, especially if you have been taking a water pill. 
Therefore, you might want to consider taking the first dose at bedtime. If there are any 
noticeable side effects such as vomiting, diarrhea, etc., I encourage you to contact me. Of course 
you won’t be experiencing any of these side effects, as you won’t be ingesting any medication. 
However, it is important to mention these things in order to mimic a patient’s visit to the doctor. 
2. For the treatment of cardiovascular disease (heart problem), you will be required to take 
Diltiazem. This drug acts by treating chest pain due to angina. This medication involves taking 
one tablet, four times daily. Medication should be taken at approximately the same time each 
day. Also, it is important that the tablets are taken as a whole and not broken, crushed or 
chewed. If you experience any bothersome side effects such as lightheadedness, nausea, etc., be 
sure to contact me. 
3. For your problem with osteoporosis (weak bones), you will be required to take two 
supplements. These include a Calcium supplement and a Vitamin D supplement The calcium 
supplement is important for improving the strength of your bone structure and it involves taking 
two 500 mg tablets daily to meet your lOOOmg calcium requirement for the day. Secondly, a 
vitamin D supplement must be taken in conjunction with the calcium supplement, as it is 
necessary in facilitating the absorption of calcium in the stomach. Two 400 lU capsules of 
vitamin D should be taken daily. Both medications should be taken with a full glass of water an 
hour to an hour and a half after eating. If you notice any side effects from the aforementioned 
supplements, please contact me whenever possible. 
4. For your bout with pulmonary disorder (breathing problems), it is important to use two 
puffers. These include a Ventolin inhaler and an Atrovent inhaler. Both of the inhalers are to 
be taken together four times daily, with 2 puffs at each usage. Because the two inhalers are to be 
used in conjunction with one another, it is important to remember to use the Ventolin inhaler 
first as it is crucial in opening the lung airways. After waiting five minutes, the Atrovent inhaler 
should be used as it is effective in dilating the bronchioles, reducing mucus secretion and 
decreasing edema. If you notice any side effects from using these inhalers such as diy mouth, 
dizziness, etc. feel free to contact me. 
5. The final medication you’ll be taking is called Restoril and it is designed to treat your 
insomnia. This medication involves simply taking a single tablet before bed. If any side effects 
such as dizziness, irregular heartbeat, etc. persist from taking this medication, contact me as 
soon as possible. 
In regards to the medication-taking, it is really a very simple procedure. Note: do a 
demonstration while explaining the procedure - but donH drop the bead into the container 
or you’ll lose it Next, I’d like to go over the procedure for ’’taking” medication. When it is 
time for you to take your medication, you simply remove one of the beads from the pill bottle 
and place it into the container. This will signify that you have taken your pill. Any questions 
about the medication-taking procedure? 
Next, I’d like to go over the procedure for using the simulated puffers. Instead of using 
an actual puffer, this procedure will require using these booklets and a container (the same 
container involved in the medication-taking procedure) to record your simulated puffer use. 
Note: hold up the booklets and do a demonstration. A single booklet will be used to represent 
each puffer. You’ll notice that inside the booklet there is a pocket on the right side of the fold 
Inside the right pocket, there are a number of stickers which will be used to represent the number 
of times in a day that you use your puffer. Therefore, when it is time to use your puffer, you 
simply take a sticker from inside the right pocket, fold it in half, and insert it into the container. 
This will signify that you have used your puffer once that day. Since you are required to use 
each of your puffers four times a day, you will have to repeat this procedure four times daily for 
each simulated puffer. Also, remember that when you are using the puffers in conjunction with 
one another, it is important to use the Ventolin Inhaler first, wait five minutes, and then use the 
Atrovent Inhaler. Any questions about this procedure? I must stress that it is of the upmost 
importance that you record your results honestly and accurately, as this is what we are truly after. 
It is very important that you take this task very seriously and try your best to adhere to your 
medication regimen. However, if you forget to take your “medications” as prescribed, don’t take 
extra doses to even it out. Stick to the medication instructions outlined on the pill bottles and 
take the next dose when appropriate. We are just as interested in the times when you forget your 
medications as when you remember them, so please be accurate. 
Here is your one week supply of pill bottles and booklets for your simulated puffers, and 
some pamphlets informing you of the side effects associated with each medication. Note: hand 
side effect sheets to participant one at a time, so they realize that there is a sheet associated 
with each specific medication. It is very important to look at the side effect sheets and learn the 
potential drawbacks related to taking each medication. In this envelope, (Note: pack the 
envelope in front of the participant) I’m packing your second week supply of pill bottles and 
booklets for your simulated puffers. On the front of the envelope, I have listed what is in the 
envelope and the date when you should begin using the medication. In this envelope, labelled 
“Confidential (Questionnaire Week 1” (Note: pack the envelope in front of the participant) I 
am enclosing one questionnaire which is to be completed during the telephone interview at the 
end of the first week. When it is time to complete this questionnaire, you simply remove the 
questionnaire from the envelope (notice that it isn’t sealed), complete it, place it back into the 
same envelope, and seal it. Finally, I am giving you a larger-sized envelope for your materials. 
This means that when you have finished using your medication from Week 1, and have 
completed your Confidential Questionnaire, place both sets of materials into this larger envelope 
and seal it. Any questions? If this all seems a bit confusing, refer to the labelled envelopes for 
information or give me a call (I’ll be providing me telephone number and the lab phone number 
shortly). Also, I’ll be phoning you the day before the telephone interview to remind you when to 
discontinue using the old medications and start using the new medications, and when to 
complete the questionnaire. 
In regards to the remainder of the sessions, we will be meeting on the same day each 
week, for the next four weeks. Locations will vary for each meeting. Week 2 will be a 
telephone interview. For Week 3, I’ll visit you at home to conduct the interview. Week 4 vsill 
be another telephone interview and for Week 5, I’ll need you to come to the school for the final 
meeting. 
It is important to remember that the first day of your medication regimen begins 
tomorrow morning. As far as the next meeting is concerned, it would be ideal if I could phone 
you in exactly one week. Obviously, it is very important that you don’t run out of medication 
and it would be greatly appreciated if we could talk on the telephone or meet on the prearranged 
dates. Therefore, the day before each scheduled meeting (regardless of whether it is a telephone 
interview or a personal interview), I will give you a telephone call to confirm our meeting. So, 
can we plan the remaining sessions (set all dates and times). Here is a medication calendar 
which includes the neimes of the investigators, my home phone, the phone number for the SALT 
lab, along with the dates and times for the remaining sessions. If for some reason you are unable 
to meet me at a particular time or won’t be home to receive my phone call, it would be ideal if 
you could call and reschedule our telephone interview or personal interview for another time that 
day. And I must stress once again that it is important to take this medication regimen seriously 
and record your results honestly and accurately. Also, it is very important to read the side effect 
sheets that I gave you earlier, so you are informed about the side effects associated with each 
medication. Do you have any final questions? Good luck with your medication regimen and I’ll 
talk to you next (fill-in appropriate date). 
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Appendix 12 
Medication Side Effects Information Sheet 
>ut‘Your Medicine: 
edipine (nye-FED-i-peen) is used to relieve and control angina (chest pain). It is also used to 
at high blood pressure (hypertension). Nifedipine may also be used for other conditions. 
ore Using This Medicine: 
1 your doctor, nurse, and pharmacist if you: 
o have allergies. 
o are pregnant or plan to become pregnant, 
o are breast-feeding. 
u are taking any other medicine, including those you buy yourself such as aspirin or cold medicine 
u have »xxy other medical problems. 
per Use of This Medicine: 
“ this medicine: 
u exactly the way your doctor told you. ) 
u even if you feel well. Keep taking it to help your medical problem. 
cautions While Using This Medicine: 
ling: 
o Do not break, crush, or chew the capsules or tablets. Swallow them whole. 
j Do not miss any doses. If you do miss a dose of this medicine, take it as soon as possible. 
However, if it is almost time for yo\ir next dose, skip the missed dose. Do not doxible doses, 
a If you have been taking this medicine regularly, do not suddenly stop taking it. 
u Do not do hard work or exercise too long or too hard. Ask. yoiir doctor how much exercise is 
safe for you. 
u See your dentist regularly to have your teeth cleaned. Check with yo\ir doctor or dentist if 
your gums swell, bleed, or feel tender. , 
a If you think you may have taken an overdose of this medicine, check with yoxxx doctor, 
u Do not give any of your medicine to others. It may hurt them, 
o Do not leave this inedicine where children can get it. 
sible Side Effects of This Medicine: 
L your doctor if you notice any of these possible side effects: Less common -- Breathing 
ficulty, coughing, or wheezing; irregular or fast or slow heartbeat; skin rash; swelling of ankles, 
:, or lower legs 
re -- Bleeding, tender, or swollen gums; chest pain; fainting; jjainful, swollen joints; trouble 
seeing 
I 
3 tell your doctor if you have any other side effects. 
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For a complete listing of Recommended Dietary Allowances, see p. 4. 
Generic Name Generic 
Brand Name Examples Supplied As Available 
Bx CalcHediol 
Calderol Capsules: 20 meg, 50 meg No 
Bx CalcitrioP 
Bocattrol Capsules: 0.25 meg, 0.5 meg No 
Bx Cholecalciferol (D3) 






otc Calciferol Drops, Drisdot Liquid: 8000 lU/ml No 
Bx Drisdol^ Capsules: 50,000 lU Yes 
Bx Calciferol^ Tablets: 50,000 lU No 
^ This product is also available as an injection. 
* Sugar free. 
^ Contains the dye tartrazine. 
Capsules: 0.125 mg No 
Tablets: 0.125 mg, 0.2 mg. No 
0.4 mg 
Solution: 0.25 mg/ml in oil No 
Type of Drug: 
Fat-soluble vitamin. Vitamin that can be stored by the body. 
How the Drug Works: 
Vitamin D promotes absorption and use of calcium and phosphate by the body and 
normal bone development and maintenance. 
Uses: 
As a dietary supplement. 
To prevent and treat rickets (a vitamin D deficiency characterized by weak bones, 
deformed skeleton, bowed legs, deformed spine, "potbelly" appearance, some- 
times flat feet and stunted growth, soft bones and deformed joints). 
To help regulate levels of parathyroid hormone. 
To prevent and treat postsurgical and other types of muscle cramps. 
To treat certain types of calcium and phosphate disorders (eg, people on chronic 
renal dialysis). 
Precautions : 
Do not use in the following situations: 
allergy to vitamin D malabsorption syndrome 
high calcium levels vitamin D toxicity 
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Use with caution in the following situations: 
hypoparathyroidism 
kidney disease 
Pregnancy: Adequate studies have not been done in pregnant women. Use only if 
clearly needed and potential benefits outweigh the possible hazards to the fetus. 
Breastfeeding: It is rK>t known if vitamin D appears in breast milk. Consult your doc- 
tor before using vitamin D supplements during breastfeeding. 
Children: Safety and effectiveness in children in doses exceeding the RDA have not 
been established. 
Tartrazine: Some of these products may contain the dye tartrazine (FD&C Yellow No. 
5) which can cause allergic reactions in certain individuals. Check package label 
when available or consult your doctor or pharmacist. 
Drug Interactions: 
Tell your doctor or pharmacist if you are taking or if you are planning to take any over- 
the-counter or prescription medications with vitamin D. Doses of one or both drugs 
may need to be modified or a different drug may need to be prescribed. The follow- 
ing drugs and drug classes inloract with vitamin D. 
Side Effects: 
Every drug is capable of producing side effects. Many vitamin D users experience no, 
or minor, side effects. The frequency and severity of side effects depend on many 
factors including dose, duration of therapy and individual susceptibility. Possible 
side effects include: 
Digestive Tract: Loss of appetite; abdominal cramps; constipation; excessive thirst; 
nausea; vomiting; diarrhea. 
Nervous System: Weakness; irritability; headache; dizziness; drowsiness. 
Other: Muscle and bone pain; increased blood pressure; Itching; runny nose; 
barbiturates (eg, phenobarbital) 
cholestyramine (eg, Questran) 
digoxin (eg, Lanoxin) 
magnesium-containing antacids (eg, Maalox) 
mineral oil 
phenytoin (eg, Dilantin) 
verapamil (eg, Calan) 
increased urination; dry mouth; metallic taste; sensitivity to light; weight loss. 
9 
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Guidelines for Use: 
•-'■•'• ■ ■• " • •••••! .. • • . • -. 
• • Eating a balanced diet and periodic exposure to sunlight usually satisfies nor- 
' ^ mal vitamin D requirements. Never use vitamin supplements as a Substitute for 
a balanced diet. 
• Compliance with dosage instructions, diet and calcium supplementation are 
•essential. . v - i ‘ 
• Swallow tablets and capsules whole.'Do not crush or chew. 
• .Notify your doctor if any of the following occurs: Weakness, lethargy, headache, 
loss of appetite, weight loss, nausea, vomiting, abdominal cramps, diarrhea, 
constipation, dizziness, excessive thirst, excessive urine output, dry mouth or 
muscle or bone pain. 
• Avoid mineral oil or magnesium-containing antacids while taking this drug. 
• Recommended Dietary Allowances (RDA)— 
Adults: 200 lU 
Pregnancy and lactation: 400 lU 
• Common sources of vitamin D—Fortified milk and milk products, eggs, sar- 
dines, fresh-water fish, chicken livers and cod liver oil. 
• The total amount of vitamin D taken each day includes both dietary intake and 
supplements. Do not take more than the RDA unless advised by your doctor. 
• Carefully measure liquid doses of vitamin D-containing products. 
If you have questions concerning vitamin D, consult your pharmacist or doctor. 
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ffS^EDAnVEi HYPNOTICS 
Estazolam, fiurazepam, quazepam, temazepam and triazolam are benzodiazep 
complete information on benzodiazepines, see p. 394. 
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ines. For 
Generic Name Generic 
Brand Name Examples Supplied As Available 
C'/v Chloral Hydrate 
Noctec Capsules: 250 mg, 500 mg Yes 
Noctec Syrup:, 250 mg/tsp, 500 mg/tsp Yes 
Aquachloral Supprettes, Chloral Suppositories: 324 mg\ 500 mg. No 
Hydrate 648 mg 
C‘!v Estazolam 
ProSom Tablets: 1 mg, 2 mg No 
C-/V Ethchlorvynol 
Placidyl Capsules: 200 mg, 500 mg. No 
750 mg^ 
C'/v Flurazopom HCI 
Dalrnane Capsules: 15 mg, 30 mg Yes 
c-ii Glutethimide Tablets: 250 mg, 500 mg Yes 
C‘fv Paraldehyde 
Para! Liquid (Oral, Rectal) Yes 
c-!v Quazepam 
Dora! Tablets: 7.5 mg, 15 mg No 
C-/V Temazepam 
RestorU Capsules: 15 mg, 30 mg Yes 
C-/V Triazolam 
Halcion Tablets: 0.125 mg, 0.25 mg No 
c-!v Zolpidem Tartrate 
Ambien Tablets: 5 mg, 10 mg No 
Contains the dye tartrazine. 
Type of Drug: 
Central nervous system depressant. Short-term sleep aid. 
How the Drug Works: * 
Non barbiturate sedatives and hypnotics cause drowsiness to aid in falling asleep by 
acting on the central nervous system. They are less likely to cause slower pulse or 
breathing rate than barbiturate drugs. 
Uses: 
To treat insomnia for a short period of time (1 to 2 weeks). Long-term use is gener- 
ally not recommended, and requires periodic medical evaluation. 
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Should sleeplessness persist, a drug-free interval of 1 or more v^eeks should elapse 
before retreatment is considered. An attempt should be made to find alternative 
. nondrug therapy in chronic sleeplessness. .    . 
Paraldehyde—lo quiet a patient and produce sleep in delirium tremens (DTs) aryd 
other psychiatric states characterized by excitement. 
Chloral hydrate—lo lessen anxiety and produce sleep before surgery. After surgery, 
chloral hydrate may be used with other medications to control pain. 
To prevent or suppress alcohol withdrawal symptoms (rectal). 
Unlabeled Uses: Occasionally doctors may prescribe ethchlorvynol as a sedative at 
doses of 100 mg to 200 mg 2 or 3 times daily. 
Precautions: 
Do not use in the following situations: 
allergy to the drug 
porphyria (ethchlorvynol and glu- 
tethimlde only) 
pregnancy (benzodiazepines only) 
sleep apnea (quazepam only) 
chloral hydrate only— 
gastritis 
heart disease, severe 












elderly or debilitated patients 
esophagitis (chloral hydrate only) 
gastritis 
impaired respiratory function 




porphyria (chloral hydrate only) 
suicide attempt, history of 
ulcer, duodenal or gastric (chloral 
hydrate only) 
Pregnancy: Adequate studies have not been done in pregnant women. Use only if 
clearly needed and potential benefits outweigh the possible hazards to the fetus. 
Benzodiazepines—Do not use during pregnancy. The risk of use in a pregnant 
woman clearly outweighs any possible benefit. 
Ethchlorvynol—UoX recommended for use during the first and second trimesters 
of pregnancy. Use during the third trimester of pregnancy may produce symptoms 
in the newborn (eg, jitteriness, hyperactivity, restlessness, irritability, disturbed 
sleep, hunger). 
Breastfeeding: Benzodiazepines, chloral hydrate and zolpidem appear in breast milk. 
It is not known if the other nonbarbiturate sedatives appear in breast milk. Consult 
your doctor before you begin breastfeeding. ' • 
Children: These drugs are generally not recommended for children.. 
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Elderly: Use with caution. Elderly patients may be more sensitive to these drugs. 
There is a risk of oversedation, "morning hangover" (grogginess in the morning), 
dizziness and confusion. Dose may neeo to be reduced. See triazolam precaution. 
Dependence: Long-term use may result in dependence. Withdrawal symptoms may 
occur when the drug is stopped. 
Lab tests may be required during treatment with these drugs. Tests may include; 
Blood counts and liver and kidney funaion tests. 
Triazolam: Short-term episodes of memory loss have been reported with the use of 
triazolam. Patients, especially the elderly, may become confused, disoriented and 
may attempt to wander after taking the drug. Upon waking in the morning, the 
patient may not remember the episode. 
Ethchlorvynot: Patients who exhibit unpredictable behavior, restlessness or excite- 
ment in response to barbiturates or alcohol may react in this manner to ethchlor- 
vynol. This drug should not be used for the management of sleep loss in the pres- 
ence of pain, unless sleep loss persists after pain is controlled with pain relievers. 
Tartrazine: Some of \hese products may contain the dye tartrazine (FD&C Yellow 
No. 5) which can cause allergic reactions in certain individuals. Check package 
label when available or consult your doctor or pharmacist. 
Drug Interactions: 
Tell your doctor or pharmacist if you are taking or if you are planning to take any over- 
the-counter or prescription medications with non barbiturate sedatives. Doses of 
one or both drugs may need to be modified or a different drug may need to be 







probenecid (eg, Benemid) 
rifampin (eg, Rifadin) 
theophylline (eg, Theo-Dur) 
tranylcypromine (Parnate) 
troleandomycin (Tao) 









digoxln (eg, Lanoxin) 
disulfiram (eg, Antabuse) 
erythromycin (eg, Ery-Tab) 
isocarboxazid (Marplan) 
isoniazid (eg, Laniazid) 
neuromuscular blocking agpnts 
alcohol 
barbiturates (eg, phenobarbitaH 
narcotic pain relievers 
chtpral hydrate only— 
anticoagulants, oral 
(eg, warfarin) 
furosemide (eg, Lasi>q 














Every drug is capable of producing side effects. Many nonbarbiturate sedative users 
experience no, or minor, side effects. The frequency and severity of side effects 
depend on many factors including dose, duration of therapy and individual suscep- 
tibility. Possible side effects include: 
Digestive Tract: Stomach pain or upset; vomiting;*nausea; diarrhea; constipation; 
indigestion and appetite changes (zolpidem only). « 
Nervous System: Confusion; excitement; sleep problems {excessive dreaming or 
nightmares); drowsiness; dizziness; hallucinations (paraldehyde only); headache; 
anxiety; depression; hysteria (ethchlorvynol only); incoordination; decreased mo- 
bility; weakness; facial numbness; disorientation; incoherence; paranoid behavior 
(chloral hydrate only); zolpidem only—amnesia; nervousness; insomnia; eupho- 
ria; vertigo (feeling of whirling motion). 
Circulatory System: Changes in blood pressure; abnormal blood counts. 
S/f//7.'Jaundice (yellowing of skin or eyes); rash; hives; itching; redness; skin and mu- 
cous membrane Irritation {zolpidem and chloral hydrate only). 
Other: Blurred vision; morning hangover (grogginess); unpleasant taste; unpleasant 
breath (paraldehyde only); dry mouth; fainting; sleepwalking (chloral hydrate 
only); prolonged hypnosis (ethchlorvynol only); upper respiratory Infections and 
urinary tract Infections (zolpidem only). 
Body as a whole (zolpidem only): Allergy; back pain; chest pain; muscle aches; fa- 
tigue; flu-like symptoms. 
Benzodiazepines only— 
Digestive Tract: Heartburn; indigestion; appetite loss. - - 
Nervous System: Nervousness; talkativeness; apprehension; irritability; euphoria 
(exaggerated sense of well being); relaxed feeling; tremor; lack of concentration; 
memory loss; sleeplessness; restlessness; tiredness; general body discomfort. 
Circulatory System: Palpitations (pounding in the chest); chest pain; heart rhythm 
disturbances. 
Other: Ringing in the ears; impairment of the senses; abnormal sensations; sore 
throat; congestion; joint pain; cramps/pain; stiffness. 
General Guidelines for Use; 
• May cause drowsiness or dizziness. Use caution while driving or performing 
other tasks requiring mental alertness, coordination or dexterity. 
• Avoid alcohol and other drugs which cause drowsiness (eg, pain relievers, 
sedatives). . 
• Do not exceed prescribed dosage. 
• May be habit forming. Do not discontinue drug abruptly, especially if you have 
a history of seizures, regardless of other antiseizure medications you may be 
taking. 
• Contact your doctor if visual changes, irregular heartbeats, chest pains, yellow- 
ing of skin or eyes, rash or unusual blooding or bruising occurs. 
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Guidelines For Individual Dosage Forms: 
• ^e^}ZO£//a2£^//)es-NiglUlimo sloop moy bo dislurbod for 1 or 2 niglus following 
stopping of the drug. 
May cause morning drowsiness, unusual tiredness in the morning or daytime 
sleepiness after using these medications for sleep. Awakening in the early 
morning may occur with temazepam and triazolam. 
Triazolam may cause short-term memory loss (see Precautions). 
Inform your doctor if you are planning to nurse or to become pregnant or if you 
become pregnant while taking this medication. 
• Chloral hydrate cause stomach upset. Take capsules with a full glass of 
water or fruit juice. 
Swallow capsules whole—do not chew. 
Dilute syrup in a half glass of water, ginger ale or fruit juice. 
• £f/?c/7/o/v/no/—Symptoms of piddiness, incoordination and stomach upset 
may be reduced if medication is taken with food. 
• G/t/fef/7/m/de—Contact your doctor if rash occurs. 
• Paraldehyde—May cause stomach upset. Take with food or mix with milk or 
iced fruit juice to Improve taste. Paraldehyde Is Irritating to the lining of the 
digestive tract and must be well diluted. 
Do not use paraldehyde in any plastic container. Do not dispense with a plastic 
spoon or syringe. 
Discard any unused paraldehyde after opening bottle. 
Do not use if liquid has a brownish color or a strong vinegar odor. 
Has a strong odor in exhaled air for as long as 24 hours after ingestion. The 
patient Is often unaware of the odor. 
Srorape—Upon exposure to light ^nd air, paraldehyde decomposes. Keep away 
from heat, open flame or sparks. Paraldehyde solidifies at approximately 54®F 
and must be liquefied before use. Do not store in direct sunlight or expose to 
temperatures above 77®F. Keep product covered in box until use. Do not use 
paraldehyde from a container that hasbeerTopened for longer than 24 hours. 
• Triazolam —Do not take when a full night's sleep and elimination of the drug 
from the body are not possible before the need to be active and functional. 
tf you have questions concerning sedative hypnotics, consult your pharmacist 
or doctor. 
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WDCut Your Medicine: 
Adrenergic bronchodilators are inhaled (breathed in) to treat asthma, bronchitis, emphysema, and 
other lung diseases. 
Before Using This Medicine: 
Read the label. Be very careful if you; 
a have allergies. 
a are pregnant or plan to become pregnant. 
□ are breast-feeding. 
□ are ta)cing any other medicine, including those you buy yourself such as aspirin or cold medicine 
a have any other medical problems. 
0 use cocaine or have used it in the past. 
Proper Use of This Medicine: 
u.se this medicine exactly the way your doctor told you. 
Precautions While Using This Medicine: 
(7arning: * 
o This medicine may come with patient directions. Read them carefully before you use the 
medicine, 
j If you use this medicine and you still have trouble breathing or your condition gets worse, 
check with your doctor right away. 
a Do not use epinephrine without a doctor's prescription unless your doctor told you that you 
have asthma. 
u Do not use epinephrine, isoetharine, isoproterenol, or racepinephrine solution if it becomes 
cloudy or turns pin3cish to brownish in color. 5 
3 If you are using the inhalation aerosol form of this medicine; — Keep spray away from your 
eyes. -- Do not take more than 2 inhalations at one time unless your doctor gave you other 
directions. Wait 1 or 2 minutes after the first inhalation to see if you need a second 
inhalation. -- Save your applicator. Refill units may be available. — Store away from heat and 
sunlight. Do not puncture, break, or burn the container, even if it is empty. 
j Do not use the inhalation aerosol form of this medicine and an adrenocorticoid or ipratropium 
inhaler at the same time. Wait 5 minutes between using the 2 medicines unless your doctor gave 
you other directions. 
u If you are using this medicine regularly and you miss a dose, use it as soon as possible. 
Then space the same amount of tfme between the other doses for that day. Do not double doses. 
3 If you think you may have taken an overdose of this medicine, check with your doctor. 
u Do not give any of your medicine to others. It may hurt them. 
j Do not leave this medicine where children can get it. 
Porsihle Side Effects of This Medicine: 
rell your doctor right away if you notice any of these possible side effects: | 
Bluish coloration of skin; dizziness (severe) or feeling faint; flushing or redness of face or skin 
[continuing); increased wheezing or difficulty in breathing; skin rash, hives, or itching; swelling of 
'ace, lips, or eyelids ^ ^ 
Qso tell your doctor about these other possible side effects: j 
Rare — Chest discomfort or pain; irregular heartbeat; numbness in hands or feet; urjusual bruising 
With high doses -- Hallucinations j 
Possible signs of overdose — Dizziness (severe); fast, slow, irregular, or pounding heartbeat 
co.ntinuing); headache (continuing or severe); increase or decrease in blood pressure (severe); nausea 
>r vomiting (continuing or severe); weakness (severe) 
?or.ie .side effects are not serious. However, tell your doctor if these bother you or do not go away: 
More common -- Nervousness or restlessness; trembling 
«.1V' I'lhi |u')i. 'I'lt'* iliiitiMl 1,11 «j,*i Ph<i r intU.;op«; i »j I Convunl. i on, Tiv:. 
>out Your Medicine: AtAOU^-f ^ 
►ratropium (i-pra-TROE-pee~um) is inhaled (breathed in) to control the symptoms of lung diseases, 
ich as chronic bronchitis and emphysema. Ipratropium may also be used for other conditions. 
ifore Using This Medicine: 
ill your doctor, nurse, and pharmacist if you: » 
u have allergies. 
o are pregnant or plan to become pregnant. * 
3 are breast-feeding. 
o are taking amy other medicine, including those you buy yourself such as aspirin or cold medicine 
u have any other medical problems. 
oper Use of This Medicine: 
e this medicine: 
u exactly the way your doctor told you. 
ecautions While Using This Medicine: 
rning: 
u This medicine usually comes with patient directions. Read them carefully. 
u For patients who are using ipratropium inhalation aerosol:’— If your doctor told you to use 
more than 1 inhalation of this medicine for each dose, wait 1 minute between the inhalations. — 
If you are also using another bronchodilator inhalation aerosol, use it first. Then wait about 5 
minutes before you use ipratropium inhalation aerosol, unless your doctor gave you other 
directions. -- If you are also using an adrenocorticoid inhalation aerosol or cromolyn 
inhalation aerosol, use the ipratropium inhalation aerosol first. Then wait about 5 minutes 
before you use the other medicine unless your doctor gave you other directions, 
u For patients who are using ipratropium inhalation solution: -- If you are using ipratropium 
inhalation solution in a nebulizer, make sure you know how to use it. Ask your doctor or 
pharmacist about this. — If you axe also using cromolyn Inhalation solution, do not mix It 
together with the Ipratroplixm Inhalation solution for use In a nebxillzer. 
a Keep the spray or solution away from your eyes. 
u If you miss a dose of this medicine, use it as soon as possible. However, if it is almost 
time for your next dose, skip the missed dose. Do not double doses. 
3 If you use a dose of this medicine and your symptoms do not get better within 30 minutes or If 
your condition gets worse, check with your doctor right away. 
3 If you have dry mouth that lasts for more than 2 weeks, check with your doctor or dentist, 
u If you think you may have taken an overdose of this medicine, check with yotu: doctor. 
3 Do not give any of your medicine to others. It may hurt them, 
a Do not leave this medicine where children can get It. 
sslble Side Effects of This Medicine: 
11 your doctor if you notice any of these possible side effects: 
are -- Skin rash or hives; ulcers or sores in mouth and on lips 
me side effects are not serious. However, tell your doctor if these bother you or do not go away: 
[ore common — Cough or dryness of mouth or throat; headache or dizziness; nervousness; stomach 
set or nausea 
> teJl your doctor If you Ijnvo any ol.liei nldo . 
opyright 1996 The United States Pharmacopeial Convention, Inc. 




Investigators: Trevor Sullivan, M.A. Program 
Leslie McDonald-Miszczaic, Ph.D 
Home Phone (Trevor); 346-2296 
Lab Phone: 346-7704 
Lab Address; BB 1067D 
Week 2 rTelephone Interview) 
Date:  Time: 
Week 3 (Home Visit! 
Date:   Time: 
Week 4 rTelephone Interview) 
Date:  Time: 
Week S (Final Interview) 
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Refill Questionnaire 
Refill Questionnaire (Weeks 1 -4) 
ID 
Visit # 
Over the course of the next half-hour or so, you’ll be asked to answer 2 
questionnaires. The first questionnaire has 15 items involving your experience with the 
medication regimen during the past week. Some questions will require you to use a rating 
scale in order for you to provide an answer. In these situations, carefully look over the 
relevant scale and choose the most appropriate rating pertaining to you. In regards to the 
second questionnaire, there will be 2 questions which you will be required to complete 
confidentially. If you have any questions at any time, please feel free to ask for assistance. 
For question #1 and #2, choose the percentage value which best pertains to your compliance 
during the last week (question #1) or yesterday (question #2). You may choose any number 
between 0 and 100. Don’t feel as if you have to use the numbers listed on the line, as these 
number are only there to help explain the scale. Choose the best number value which 
pertains to you (for example, 80%, 75%, 67%, etc.). 
1. How would you rate your compliance with your medication regimen over the last week? 
100% 75% 50% 25% 0% 
2. How' would you rate your compliance with your medication regimen yesterday? 
I I I I ^ I  % 
100% 75% 50% 25% 0% 
For question #3, circle “Yes” or “No”, depending on which answer best pertains to you. 
3. Did you incorporate any specific strategies that help you to remember to take your 
medications? 
(Yes / No) 
If you answered “Yes” or “No” to the above question, read over the different strategies 
listed beside letters “a, b, c, d, e, f, g, h, and i” and circle “Yes” if you used this strategy or 
“No” if you didn’t use the strategy. If you circled “Yes”, then estimate what percentage of 
the time during the last week that you used this strategy to help you remember to take your 
medication. 
a. Make a list of all medications, including correct times and contexts. 
(Yes / No) % 
b. Mentally rehearse the medication regimen at the beginning of the day. 
(Yes / No) % 
d. Leave medication in familiar spots so you won’t forget them. 
(Yes / No)  % 
e. Look back at the day retrospectively to remember if you took your medication. 
(Yes / No)  % 
f Concentrate extra hard on remembering to take medication correctly. 
(Yes / No)  % 
g. Write reminder notes for yourself 
(Yes / No)  % 
h. Put all of your pills into one bottle when leaving the house. 
(Yes / No)  % 
I. Other  
(Yes / No)  % 
Note: if participant states more than one strategy, ask the following two questions: 
Which strategy did you use the most?  
Which strategy was most effective?  
4a. Did you find that your medication compliance has changed during the last week? 
(Yes / No) 
b. Has your compliance improved or declined?  
c. How much has your compliance improved/declined?  % 
5a. How complex did you find the medication regimen? 
(Extremely Complex / Very Complex / Moderately Complex / 
Mildly Complex / Not Complex) 
b. If so, what primarily did you find complex about the regimen? 
6a. How difficult did you find it to incorporate your medication regimen into your daily 
schedule (i.e., inconvenient)? 
(Extremely Difficult / Very Difficult / Moderately Difficult / 
Mildly Difficult / Not Difficult) 
b. If so, what primary facet of the regimen was of particular inconvenience? 
7a. How often did you have problems remembering to take specific medications in conjunction 
with one another. 
(Always / Often / Sometimes / Rarely / Never) 
b. If so, which medication combination(s) is posed a problem and what was the primary 
obstacle which prevented you from taking your medication? 
8a. Are there any specific situations that made it difficult for you to take your 
medication correctly? 
(Yes / No) 
b. If so, describe the primary situation(s). 
9a. How often did you forget to take your pills when you are at home? 
(Always / Often / Sometimes / Rarely / Never / Not Applicable) 
b. If so, what was the primary reason that caused you to forget to take your pills when you are 
at home? 
1 Oa. How often did you forget to use your puffers when you are at home? 
(Always / Often / Sometimes / Rarely / Never / Not Applicable) 
b. If so, what was the primary reason that caused you to forget to use your puffers when you 
are at home? 
1 la. How often did you forget to bring your pills with you when you left home? 
(Always / Often / Sometimes / Rarely / Never / Not Applicable) 
b. If so, what was the primary reason that caused you to forget to bring your pills with you 
when you left home? 
12a. When you remembered to bring your pills with you wlien you left home, how often did you 
forget to take them? 
(Always / Often / Sometimes / Rarely / Never / Not Applicable) 
b. If so, what was the primary reason that caused you to forget to take your pills when you left 
home? 
13a. How often did you forget to bring your puffers with you when you left home? 
(Always / Often / Sometimes / Rarely / Never / Not Applicable) 
b. If so, what was the primary reason that caused you to forget to bring your puffers with you 
when you left home? 
14a. When you remembered to bring your puffers with you when you left home, how often did 
you forget to use them? 
(Always / Often / Sometimes / Rarely / Never / Not Applicable) 
b. If so, what was the primary reason that caused you to forget to use your puffers when you 
left home? 
15a. Have you started to take any new medications since beginning participation in this study 
(i.e. prescribed medication for an illness)? 
(Yes / No) 
Note: if participant answers “yes” above, ask the following questions: 
How many new medication(s) are you presently taking?  medications 
How many times daily are you required to take each medication(s)? 
In your best estimate, how long will you be required to take these medication(s) 
  days / weeks / months 
Post-Refill Interview Questions 
1. Describe your typical daily medication regimen. 
2a. Does your typical medication regimen vary significantly from day-to-day? 
(Yes / No) 
b. If so, how does your typcial medication regimen vary significantly from day-to-day? 






Confidential Questions for Refill and Final Interview 
In this questionnaire, I would like you to answer a few questions involving your 
attitude towards the medication regimen. Please take your time and answer each of these 
questions to the best of your ability. Avoid signing your name on this questionnaire as it is 
important to preserve your anonymity. When you have completed the questionnaire, place 
it in the envelope and seal it I won’t be looking at this questionnaire until the end of the 
study, so please provide honest answers. If you have any questions at any time, please feel 
free to ask for assistance. 
16. Did you experience any days where you purposely chose not to take any medication? 
(Yes / No) 
If you answered “yes”, what were your reason( s) for doing so? (circle all that apply) 
a. Too busy to take medication. 
b. Didn’t feel like taking medication. 
c. Find myself losing interest in the study. 
d. Encountered personal problems. 
e. Had a bout with illness, 
f Other 
How many days or parts of days, did you choose not to take your medication since our last 
meeting one week ago? 
Note: you can use partial days (i.e., .5 or .25 if appropriate).  days 
17a. Since the last time we met, how important is it for you to remember to take your medication 
correctly for the purposes of this study? 
a. Extremely Important 
b. Very Important 
c. Moderately Important 
d. Mildly Important 
e. Not Important 
b. Why was it important or not important for you to remember to take your medication 
correctly? 
Note: please write or print very clearly. 
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Time-Based Prospective Memory Task 
Time-Based Prospective Memory Task 
Note: this task is to be presented at the end of the Refill Visit (Week 2). 
This should just about wrap-up our meeting. The next meeting will be held at your house 
for about 30 minutes (Home Visit - Week 3). As I mentioned earlier, it is important to confirm 
every meeting in order to keep the medication schedule consistent and ensure that you don’t run 
out of medication. Unfortunately, I will be unable to call you the day before our meeting to 
confirm as 1 will be out of town. For the next little >\^ile, ITl be at my family cottage in Esker 
Lake and I’m afraid we don’t have a phone. So, I was wondering if you could phone the SALT 
lab sometime between 9:00 a.m. and 1:00 p.m. and leave a message on the answering machine to 
confirm the meeting. When you phone the lab, just leave your name and confirm the time of our 
meeting for the next day. Also, I should mention that it is very important that you phone 
between 9.00 a.m. and 1:00 p.m. as there will be testing going on in the lab shortly after 1:00 
p.m.. When this happens, the telephone ringer may interrupt another testing session. Thank you 
and I’ll see you next time. 
Note: Make new message on answeing machine for Week 2 
Note: Put sign on telephone to not answer it between 9:00a.m. - 1:00 p.m. 
Note: Phone participant back at 4:00 p.m. to confirm the meeting 
Return-Call Message 
Hi, this is Trevor Sullivan. I’m just calling to confirm our meeting for tomorrow. 
Fortunately, I got back from my trip earlier than I anticipated. I’m looking forward to meeting 
you tomorrow at (say time). See you then! 
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Rating Questionnaire 
Rating Questions for Final Interview 
ID 
The following questionnaire asks that you read each of the questions carefully and 
rate your recall for each specific question. For example, in question #18, you are asked to 
rate how well you remember what each specific medications is designed to treat This 
answer is to be rated on a scale ranging from 0% (none of the medications) - 100% (all of 
the medications). Below question 18 there is a glossary explaining what each rating 
represents. Don’t feel as if you have to choose one of the suggested ratings. If another 
rating is more appropriate, select that one. When you have finished rating the question, 
write your answer in the blank space provided (next to the % sign). 
18. Do you remember what each specific medication is designed to treat? 
100% 75% 50% 25% 0% 
100% -1 remember what all of the medications are designed to treat. 
75% -1 remember what most of the medications are designed to treat. 
50% -1 remember what half of the medications are designed to treat. 
25% -1 remember what some of the medications are designed to treat. 
0% -1 remember what none of the medications are designed to treat. 
19. Do you remember how many times daily each specific medication is to be taken? 
100% 75% 50% 25% 0% 
100% -1 remember how many times daily all of the medications are to be taken. 
75% -1 remember how many times daily most of the medications are to be taken. 
50% -1 remember how many times daily half of the medications are to be taken. 
25% -1 remember how many times daily some of the medications are to be taken. 
0% -1 remember how many times daily none of the medications are to be taken. 
20. Do you remember the amount of each specific medication that is to be taken daily? 
100% 75% 50% 25% 0% 
100% -1 remember the amount of all medications that are to be taken daily. 
75% -1 remember the amount of most of the medications that are to be taken daily. 
50% -1 remember the amount of half of the medications that are to be taken daily. 
25% -1 remember the amount of some of the medications that are to be taken daily. 
0% -1 remember the amount of none of the medications that are to be taken daily. 
21. Ek) you remember which medications are to be taken in conjunction with one another? 
! ! ! ^ !  % 
100% 75% 50% 25% 0% 
100% -1 remember all of the medications that are to be taken in conjunction with one another. 
75% -1 remember most of the medications that are to be taken in conjunction with one another. 
50% -1 remember half of the medications that are to be taken in conjunction with one another. 
25% -1 remember some of the medications that are to be taken in conjunction with one another. 
0% -1 remember none of the medications that are to be taken in conjunction with one another. 
22. Do you remember the context in which each medication is to be taken (i.e. with water)? 
100% 75% 50% 25% 0% 
100% -1 remember the context in which all of the medications are to be taken. 
75% -1 remember the context in which most of the medications are to be taken. 
50% -1 remember the context in which half of the medications are to be taken. 
25% -1 remember the context in which some of the medications are to be taken. 
0% -1 remember the context in which none of the medications are to be taken. 
23. Do you remember the side effects associated with each medication? 
100% 75% 50% 25% 0% 
100% -1 remember the side effects associated with all of the medications. 
75% -1 remember the side effects associated with most of the medications. 
50% -1 remember the side effects associated with half of the medications. 
25% -1 remember the side effects associated with some of the medications. 




Recall Questions for Final Interview 
ID 
Now that we have completed the 5 week study, I would like you to provide as many 
details about your medication regimen as possible. Don’t worry if you cannot remember all 
the details of your regimen, but please take your time and try your best Also, don’t worry 
about spelling or even recalling all of the details perfectly. It is great if you can do this, but 
it is just as important to provide us with as many details as possible (even incomplete ones). 
For the remaining questions, you are asked to provide a detailed response. Please write or 
print very clearly. You may ask for additional paper if you need it Remember, provide as 
many details as possible, even if they are incomplete. 
24 .. Please name as many of your medications as possible and describe the condition that each 
medication is designed to treat. 
25. Please list how many times daily each specific medication should be taken. 
Note: if you cannot recall the names of medications use numbers to differentiate 
between them. 
26. Please describe the amount of each medication that is to be taken daily? 
27. Please describe the medication combinations that are to be taken in conjunction with one 
another. 
28. Please describe the context in which each medication should be taken (i.e., with water, 
with food, etc.). 
29. Please list major side effects associated vvdth each individual medication. 
Note: please be specific about which side effects coincide with each individual 
medication. 
Thank you for your participation! 
Appendix 19 
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Debriefine Sheet 
Debriefing 
Some estimates suggest that 30 - 45% of older adults do not take their medication 
correctly (Isaac, Tamblyn, & McGill-Calgary Drug Research Team, 1993). The implications for 
older adults’ health and the cost of health care due to complications is enormous. Are the 
elderly simply forgetting to take their medication or are there other factors which contribute to 
poor medication compliance? 
This study examines the self-reported medication compliance and the actual compliance 
behaviours of a younger sample of university students and older participants in order to examine 
(a) changes in self-reports and compliance behaviour over a short-term period, (b) concordance 
between such self-assessment and actual compliance behaviours over time, and (c) the amount 
and types of medication information that individuals recall after they have been participating in a 
medication program for some time. Assessing both self-reports and actual compliance 
behaviours is very important. The two measures do not agree (often we underestimate or 
overestimate our compliance). Given that self-reported compliance is the measure used by 
physicians to modify regimens, examination of such inaccuracy is important to adults’ physical 
well-being, 
To understand the relation between our self-reported compliance rates and our memory 
ability, we asked you to perform a variety of memory tasks in this study. In order to get an 
accurate measure of some types of memory, we asked you to (a) tear out the messy page from 
your questionnaire booklet and write the name of the questionnaire in the top right-hand comer, 
(b) tell the researcher when 20 minutes had elapsed, so that he could receive a phone call, and 
(c) telephone the SALT lab and leave your name on the answering machine in order to confirm 
the meeting for Week 3 (Home Visit). The tasks were actually a planned portion of the 
experiments so that we could measure your memory for performing these tasks (just as if we had 
asked you to remember to take a medication when you saw it, remember to take your next pill in 
20 minutes, or phone the SALT lab to receive a refill for your medication). We apologize for 
giving you a cover story for these tasks, but this information is crucial for understanding how 
different parts of the memory system are used to remember our medications. 
You were also asked to perform several other memory tasks. These included: matching 
the appropriate symbol with the appropriate number, remembering word pairs and making a 
prediction on how many you thought you could remember, and looking at a series of sentences 
on flash cards and making new sentences from the underlined words. The reason that we asked 
you to perform these tasks is because we feel that your performance on these tasks may be 
related to performance on the medication regimen. 
We asked you to participate in this study for a period of four weeks because most studies 
of medication compliance completed to date have not taken place over a period of weeks. Let’s 
face it, our compliance with our medications changes as we become more accustomed to our 
medication regimen (sometimes we develop strategies to help our compliance so it improves, 
and sometimes our compliance gets sloppy with time). We asked healthy older adults to 
participate in this study to closely examine the effects of memory and regimen complexity on 
self-reports and actual compliance. 
Before you leave, I would like to ask you to please not say anything at all about this 
study to anyone. If f>eople who are still participating in this study hear about it, they may start 
forming some expectations about it and this may influence their answers to the questionnaires. 
So, regardless of the temptation, could you promise not to discuss this study with anyone to 
ensure its success? Do you have any questions? 
Would you like to tell me your address so I can send you a copy of the study’s results? 
The study and the analysis will take some months to complete, but we would like to tell you 
about the findings. Thank you very much for your participation. It has been invaluable. 
Medication Compliance Questions 
1. What is the paradox that exists concerning older adults’ cognitive abilities and their 
medication regimens? 
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Figure 1. 
Self-Reported Compliance Ratings of Young Adults over Time 
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Figure 2. 
Self-Reported Compliance Ratings of Older Adults over Time 
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Figure 3. 
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Figure 4. 
Actual Compliance Ratings of Older Adults over Time 
Week Number for Actual Compliance 
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Table 1 
Means and standard deviations for Young and Older Adults on Demographic Variables, Mood, 
and Memory Beliefs 
Youn2 Adults Older Adults t-value 
A T ^ 




Daily social activities 
Perceived Overall State of Health 
Perceived State of Health Compared 
With Peers 
Yearly Visits to Family Physician 
Number of Prescribed Medications 




Internal Strategy Use 































Note. *p< 05. **p< 01. ***p< 001. PIQ = Personal Information Questionnaire. CES-D = Centre 
for Epidemiology Depression Scale. MIA = Metamemory in Adulthood Questionnaire. Higher 
scores on Personal Information variables indicate more daily social activity, lower perceptions of 
overall health when compared to a perfect state of health, lower perceptions of overall health 
when compared to peers, more yearly visits to family physician, and greater number of 
prescribed medications in the last two years. Higher scores on Depression Questionnaire (CES- 
D) indicate higher levels of depression. Higher scores on Metamemory in Adulthood 
Questionnaire (MIA) indicate lower levels of anxiety (Anxiety Scale), increased use of internal 
strategies (Internal Strategy Scale), increased use of external strategies (External Strategy Scale ), 
and lower levels of self-efficacy (Self-Efficacy Scale). 
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Table 2 
Means and standard deviations for Young and Older Adults on Self-Reported Compliance 
Ratings and Actual Compliance Scores 
Vr\iinn- A Hu Uc 
a. X XXXVXXV^ 
AHlll+C 
Variable (n=30) (n=30) 
Self-Reported Compliance Ratings 
Actual Compliance Scores 
330.73 (37.73) 
60.83 (38.08) 
351.33 (55.14) -1.69 
39.07(34.18) 2.33* 
Note. *p<.05. **p<.01. ***p<.001. Higher scores on Self-Reported Compliance Rating indicate 
higher perceived ratings of compliance. Higher scores on Actual Compliance indicate superior 
compliance performance. 
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Table 3 
Means and standard deviations for Young and Older Adults on Self-Reported Compliance and 


























Note. *p<.05. **p< 01. ***p<.001. Higher scores on Intercept Values indicate a higher starting 
point for self-reported compliance and actual compliance scores. Higher scores on Slope Values 
indicate greater change over time for self-reported compliance and actual compliance scores. 
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Table 4 








All Subjects Combined 
Pearson r .125 .079 
Semi-partial correlation .225 .058 
Young Adults 
Pearson r .301 .198 
Semi-partial correlation .320 .184 
Older Adults 
Pearson r .171 .029 
Semi-partial correlation .189 -.032 
Actual Compliance 
All Subjects Combined 
Pearson r .019 -.113 
Semi-partial correlation -.047 -.122 
Young Adults 
Pearson r .064 -.107 
Semi-partial correlation .093 -.109 
Older Adults 
Pearson r -.182 -.174 
Semi-partial correlation -.156 -.138 
-.236 .068 .032 14.40 
-.349 .032 .077 
•224 .009 .163 23.37 
-.324 .007 .106 
-.085 .045 .136 8.26 
.221 .006 .119 
.176 -.056 .045 5.66 
.186 -.056 .005 
-.010 .010 -.150 5.08 
.015 .120 -.178 
.012 -.150 .049 8.05 
.115 -.127 .044 
Note. EBPM = Event-Based Drosnective memorv^ TBPM = Time-based nrosnective memorv' 
rvo — c u^i 
ov_ ‘ ociiitiict v.-v7iiau uciicai. 
cmr —   
oi 1 ~ ijuujcci-|jci luiiiitu laaiv. 
partial correlations were derived from regression equations with simultaneous entr>’ of all 
memory predictors. 
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Table 5 
Predictors of Self-Reported and Actual Compliance Slope Values for Young and Older Adults 
Slope 
FRPIv/l TRPA/I «;PT P9 
Self-P-Cported Compliance 
All Subjects Combined 
Pearson r -.350 
Semi-partial correlation -.297 
Young Adults 
Pearson r -.400 
Semi-partial correlation -.381 
Older Adults 
Pearson r -.369 
Semi-partial correlation -.348 
Actual Compliance 
All Subjects Combined 
Pearson r .222 
Semi-partial correlation .101 
Young Adults 
Pearson r .067 
Semi-partial correlation .048 
Older Adults 
Pearson r .308 
Semi-partial correlation .265 
-.039 -.204 -.145 -.087 14.67 











.214 -.148 .026 22.78 
.158 -.202 .171 
-.116 -.169 -.144 16.52 
.085 -.062 .016 
.279 .074 .094 11.13 
.211 .034 -.098 
.197 .168 -.211 24.80 
.186 .276 -.381 
.131 -.112 .275 19.48 
-.040 -.254 .199 
Note. EBPM = Event-Based prospective memory. TBPM = Time-based prospective memory'. 
DS = Digit Symbol. SC = Sentence Construction. SPT = Subject-performed task. The semi- 
partial correlations were derived from regression equations with simultaneous entr>' of all 
memory predictors. 
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Table 6 
Means and standard deviations for Young and Older Adults on Perceptions of Recall and Actual 
Recall of the Medication Regimen 
A/tiiltc t 
Variable (n=30) (n=30) 
Perception of Recall Score 442.17(74.68) 405.67(122.32) 1.39 
Actual Recall Score 28.08 (4.50) 24.17 (7.40) 2.48* 
Note. *p<.05. **p<.01. ***p<.001. Higher scores on Perception of Recall indicate higher 
perceived recall of medication regimen. Higher scores on Actual Recall indicate higher actual 
recall of medication regimen. 
